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Abstract
Under iron deficient conditions, gram-negative bacteria like E. coli secrete 
siderophores to chelate iron in the extracellular medium. Ligand-gated porins (LGPs) 
transport the ferric siderophore complexes across the outer membrane (OM) of the 
bacterium. The C-terminal domains of LGPs form channels across the OM, which are 
occluded by their N domains. The LGPs, FepA and FhuA transport ferric enterobactin 
(FeEnt) and ferrichrome (Fc) respectively into the periplasm of E. coli. 
The FeEnt-FepA binding interaction binding reaction is biphasic with two 
binding stages, B1 and B2 which may reflect two anatomical locations or two kinetic 
stages. The interaction is also specific and is characterized by high affinity. Binding 
competition experiments between FeEnt and other ferric siderophores show that the 
initial adsorption of the ligand happens with bonafide specificity. The interaction is 
unaffected by unrecognized ferric siderophores like ferrichrome and ferric 
Agrobactin. The triscatecholate and cognate siderophore, ferric TRENCAM competes 
with FeEnt. Despite being triscatecholate, ferric corynebactin only partially inhibits 
the binding of FeEnt. When compared to FeEnt, the iron center in ferric corynebactin 
has the opposite configuration of the chelating groups around the iron. Further more, 
the ferric siderophore is larger in size than FeEnt. The partial inhibition presumably 
reflects the fact that the molecule participates in the initial stage of binding, B1 but 
does not progress to B2 in the biphasic binding. 
The surface loops of FepA bind and enclose FeEnt at the top of the barrel. 
Site-directed mutagenesis studies show that aromatic residues like tyrosine 481 and 
638 make a major contribution to the high affinity of the interaction.  Intriguingly, 
some of the aromatic residues like tyrosines 478, 495 and trypophan 101 although 
xi
located in the outer reaches of the protein are crucial to the uptake reaction despite 
making only modest contributions to the binding reaction. 
Upon binding and closure of the loops, the N domain of FepA undergoes a 
conformational change to allow FeEnt to pass through the barrel. Labeling 
experiments with fluorophores and cysteine mutants of FepA show that this process 
involves the extrusion of the N domain from its location within the beta barrel. This is 
evidenced by the fact that G54C in the N domain is labelled during the transport, but 
G565C in the interior of the barrel is not labelled. The model of transport envisages 
the specific adsorption of the ferric siderophore followed by the closure of the loops 
over the bound ligand.  Subsequently the N domain extrudes out of the barrel and 





The biological utility of iron stems from its ability to form a multitude of 
complexes with O, S, and N ligands. These complexes readily undergo acid-base and 
electron transfer reactions. In biological systems, iron undergoes changes between 
Fe2+ and Fe3+ states in response to the redox status of the environment. 
Iron containing proteins participate in a variety of essential metabolic 
processes that sustain life. For example, proteins containing heme perform crucial 
roles in the electron transport system. Several cytochromes serve as members of the 
electron transport chain. The iron centers of these proteins are central to the 
oxidoreductive functions of these proteins. Cytochrome oxidase is involved in the 
activation of oxygen (Vernon 1960, Blaylock 1963). Peroxidase and catalase work in 
the reduction of hydrogen peroxide. Proteins containing iron-sulfur clusters play 
several important roles. The enzymes, aconitase (Martius 1937, Breusch 1937, 
Dickman 1950, Dickman 1951) and succinate dehydrogenase (Singer 1955) function 
in the citric acid cycle. Ferredoxin is involved in the electron transport chain 
(Mortenson 1963). Other processes involve proteins carrying non-heme and non-iron-
sulfur cluster forms of iron. Examples include proteins involved in nucleic acid 
synthesis like ribonucleotide reductase (Brown 1968). Superoxide dismutase is crucial 
for protection from free radicals (Yost 1973). Therefore, it is not surprising that iron is 
a premium nutrient for microorganisms including bacteria and fungi. Several studies 
have reported the correlation between the growth and virulence of several pathogenic 
bacteria and the supply of iron. These include gram-positive (Staphylococcus (Szabo 
2
1971, Trivier 1996)), gram-negative (like Neisseria (Kellog 1968)) and acid-fast (like 
Mycobacterium) pathogens (Kochan 1963, Golden 1974). 
Besides its role in bacterial metabolism, iron also directly affects the 
pathogenicity of bacteria. In diphtheria, an infection caused by Corynebacterium 
diphtheriae, the production of diphtheria toxin is regulated by iron availability 
(Pappenheimer 1936). Diphtheria toxin ADP-ribosylates elongation factor, EF-2.  The 
levels of expression of diphtheria toxin increase in proportion to the degree of iron 
deficiency. Iron repletion decreases toxin production. 
Bacteria require iron only in micromolar concentrations. However, several 
factors impede iron acquisition forcing the bacteria to evolve several different 
strategies. Under anaerobic conditions, iron exists in the Fe2+ oxidation state. Fe2+ iron 
is soluble and bio-available. Therefore, anaerobes directly accumulate Fe2+ iron. 
Aerobes are not so fortunate. Under aerobic conditions, iron exists predominantly as 
Fe3+ iron. At neutral pH, Fe3+ forms insoluble oxy- hydroxy polymers, which are not 
available for bacterial assimilation.  Bacterial species inhabiting the human colon face 
additional constraints in their iron acquisition. Numerous host proteins like lactoferrin 
and transferrin sequester iron, further depleting the sources of the element. In the
human colon, the concentration of free iron is of the order of 10 -18 M (Bullen 1978, 
Neilands 1980). This concentration is too low to support the iron requirements of 
microorganisms (Klebba 1982). 
Several gram-negative bacteria inhabit the human colon. This includes 
pathogenic and non-pathogenic species of Escherichia. Pathogenic E. coli cause 
several infectious diseases. Enterotoxigenic E. coli are an important cause of 
traveler’s diarrhea (Dupont 1971). Enteroinvasive, enteropathogenic and 
enterohemorrhagic E. coli are implicated in a variety of disorders including dysentery, 
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bacterial gastroenteritis and the hemolytic-uremic syndrome. Despite the advent of 
several antibiotics, E. coli continues to be an important causal factor of human 
morbidity. 
Siderophores
Commensal and pathogenic gram-negative bacteria share several strategies to 
acquire iron in free iron-deficient environments. Bacteria employ certain proteins in 
their outer membrane (OM) to capture heme from hemoglobin or directly acquire iron 
from host proteins. Another prominent strategy involves the expression of iron-
chelators called siderophores (Lankford 1973, Neilands 1981). Bacteria and fungi 
export these molecules into the extracellular medium. More than 100 different 
siderophores have been reported (Neilands 1981, Neilands 1991). In general, 
siderophores are organic molecules weighing less than 1000 Da. They are secreted 
under iron-deficient conditions. They possess phenolate and carboxylate oxygen 
ligands. These ligands bind iron in the Fe3+ state with high affinity. They have much 
lower affinity for Fe2+ iron. Based on their chemistry, siderophores are broadly 
classified into catecholates and hydroxamates (table 1). This traditional classification 
has been extended to recognize carboxylate, heterocyclic and mixed siderophores.  
Enterobactin, a tricatecholate siderophore is a native siderophore of E. coli
(Pollack 1970, O’Brien 1970). Enterobactin contains three dihydroxybenzoyl serine 
(DHBS) moieties. The 3 serines form the lactone ring backbone of the siderophore. 
The iron center of the siderophore is provided by the three catechol groups. The 
molecule possesses trivalent symmetry around the axis connecting the iron center and 
the center of the lactone ring. Enterobactin possesses extremely high affinity for Fe3+. 
The association constant has been reported to be as high as 1052. Enterobactin binds 
Fe3+ forming the ferric siderophore, ferric enterobactin (FeEnt). FeEnt is negatively 
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charged (-3). Its molecular weight is 729. Enterobactin also binds Vanadium and 
Gallium with high affinity. The crystal structure of FeEnt is not available. However, 
the crystal structure of Vanadium enterobactin (VEnt) has been solved (Karpishin 
1992). FeEnt is expected to resemble VEnt. In VEnt, vanadium is coordinated by six 
deprotonated hydroxyl groups (Figure 1). 
Corynebactin (also called bacillibactin) is a catecholate siderophore produced 
by the gram-positive bacilli, Corynebacterium and Bacillus (Budzikikiewicz 1997, 
May 2001). The siderophore is formed by three dihydroxybenzoyl threonylglycine 
moieties. The threonyl moieties form the trilactone backbone. Similar to enterobactin, 
the three catecholates form the iron center. However, the substitution of threonyl 
glycines for the smaller serines renders the conformation of ferric corynebactin to be 
opposite of FeEnt. While enterobactin forms a •-complex with Fe3+, corynebactin 
forms a -complex. Corynebactin has a molecular weight of 882.  
Ferric TRENCAM (Rodgers 1987) and Ferric MECAM (Venuti 1979, Harris 
1979) are synthetic ferric siderophores belonging to the catecholate group. In 
TRENCAM, a tertiary amine substitutes for the lactone ring in enterobactin and 
corynebactin. The iron centers of ferric TRENCAM (FeTRENCAM) and ferric 






Figure 1. Catecholate and hydroxamate siderophores. A. Enterobactin, B. TRENCAM, C. 
Corynebactin, D. Agrobactin, E. Ferrichrome (Neilands 1952, Pollack 1970, O’Brien 1970, Ong 1979, 
van der Helm 1980, Rodgers 1987, Karpishin 1992, Budzikiewicz 1997). The crystal structures of 
vanadium enterobactin and apoferrichrome are shown to the right of the enterobactin and ferrichrome 
respectively. 
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Table 1. Properties of siderophores. In the column on the right, charge refers to the net charge of the 
ferric siderophore complex (Neilands 1952, Pollack 1970, O’Brien 1970, Ong 1979, van der Helm 
1980, Rodgers 1987, Karpishin 1992, Budzikiewicz 1997). 
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Agrobactin is another catecholate siderophore, secreted by the plant pathogen, 
Agrobacterium tumefaciens (Ong 1979). Agrobactin is characterized by a threonyl 
peptide of the triamine, spermidine acylated with 3 residues of 2, 3-
dihydroxybenzoate (DHB). The carbonyl group of one of the DHB residues 
participates in an oxazoline ring with the β -hydroxyl of the threonine moiety. In 
contrast to enterobactin, the bulk of the third aromatic ring is displaced away from the 
iron center. Therefore, only two of the catechol groups participate in chelating iron. 
The fifth and sixth ligands derive from the nitrogen of the oxazoline ring and from the 
proximal hydroxyl of the third catechol group. The net charge of ferric agrobactin is -
2.5. Several other natural and synthetic catecholate siderophores have been reported. 
The hydroxamate siderophore, apoferrichrome is secreted by the smut fungus, 
Ustilago sphaerogena (Neilands 1952). Apoferrichrome is a cyclic hexapeptide of 
triglycyl-tri (N5 hydroxy-N5 acetyl-l- ornithine). Apoferrichrome binds Fe3+ forming 
neutral ferrichrome (Fc). In Fc, iron is coordinated by 3 deprotonated hydroxyl groups 
and 3 carbonyl oxygens of the hydroxamate moieties. The molecular weight of Fc is 
660. Other members of the hydroxamate group include aerobactin produced by 
Aerobacter (Gibson 1969) and some plasmid-bearing strains of E. coli (Neilands 
1981). 
Ligand-gated porins
Bacteria secrete the siderophores into the extracellular fluid. The chelators 
capture Fe3+ iron from its insoluble polymers. These molecules also strip iron from 
host proteins (Tidmarsh 1983). The next step in iron acquisition is the internalization 
of these ferric siderophores. In gram-negative bacteria, the envelope includes the 
cytoplasmic membrane, a multilamellar sheet of peptidoglycan, linked to a lipid 
bilayer, the OM. The OM is in turn is surrounded by the polar lipopolysaccharide (O-
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antigen). The cell wall restricts the entry of extraneous substances. However, the OM 
of E. coli houses proteins that form water-filled channels. These pore forming proteins 
are called porins. 
Several different classes of porins are recognized. These include the general 
porins, specific porins and ligand-gated porins (LGPs). General porins allow the free 
incursion of molecules smaller than 600 Da (Nikaido 1985). However, the 
siderophore complexes are typically larger than this limit. Therefore, bacteria have 
evolved specific mechanisms to internalize the ferric siderophores. Specific receptors 
belonging to the class of porins called ligand-gated porins, transport ferric 
siderophores. LGPs transporting other substrates like vitamin B12 (BtuB) and 
nucleosides (TsX) have also been described. These porins are ligand-gated in the 
sense that they are not open channels like the general porins. Upon ligand binding, 
these proteins achieve the requisite conformation to enable its transport (Rutz 1992, 
Jiang 1997, Killmann 1993).  
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Figure 2. Schematic representation of the gram-negative bacterial envelope. The figure represents 
the known components of the pathway of FeEnt transport. Questions remain about the role of TonB in 
this scheme (see text for details). The ferric siderophores FeEnt and Fc bind to the LGPs, FepA and 
FhuA. FeEnt is transported by FepA across the outer membrane and enters the periplasm. This process 
requires the function of the inner membrane protein, TonB. FeEnt is then bound by the periplasmic 
binding protein, FepB, which delivers it to the inner membrane permease, FepCDG. The ferric 
siderophore is transported across the inner membrane. Iron is released from enterobactin by the activity 
of reductase and Fes esterase. The reductase reduces iron to its ferrous form and the esterase cleaves 
enterobactin to give dihydroxybenzoyl serines (DHBS). The ferrous iron binds to the Fur (Ferric uptake 
regulator) repressor and the complex binds to the fur regulation element (FRE) and negatively regulates 
the transcription of the genes coding for the proteins involved in FeEnt transport (FepA regulon).
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The ferric siderophore transporters share several structural and functional 
similarities. They are usually named after the ligands that they transport. FepA 
(originally named FeEnt permease A, later renamed as FeEnt porin A) transports 
FeEnt (Pugsley 1976, Wayne 1976). FepA also transports the ferric siderophores, 
Femyxochelin C (Trowitzsch-Kienast 1996, Rabsch 1999), FeMECAM and 
FeTRENCAM (Heidinger 1983, Thulasiraman 1998). FhuA (Ferric hydroxamate 
uptake) receives Fc (Wayne 1975). FecA (Ferric citrate) acts on ferric citrate 
(Wagegg 1981). These proteins are generally larger than 70 kDa. Their occurrence in 
the OM of gram-negative bacteria is a reliable indicator of iron deficiency (Klebba 
1981). 
A specific protein binding sequence, usually a 19-bp inverted repeat called the 
fur box, flanks the genes encoding these proteins. Fur stands for ferric uptake 
regulator proteins. Under iron rich conditions, the concentration of Fe2+ iron inside the 
cell rises and is taken up by the Fur protein. Upon Fe2+ binding, the affinity of fur for 
fur box rises dramatically. Fur proteins bind with high affinity to the fur box (De 
Lorenzo 1988). Fe2+-fur binding to fur recognition element (fur box) down-regulates 
transcription from genes encoding these LGPs. Under iron deficient conditions, fur 
releases the fur-box. The genes encoding the LGPs and their downstream partners in 
the iron acquisition are clustered together in the E. coli genome. The fepA (Lundrigan 
1986) gene cluster also houses the genes encoding the biosynthetic components for 
enterobactin. 
Upon entry into the periplasm, the ferric siderophore is taken up by the 
periplasmic binding protein. For FeEnt, FepB fulfills this role. FepB delivers the 
FeEnt to the inner membrane permeases (Pierce 1983, Elkins 1989, Stephens 1995, 
Sprencel 2000). 
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The inner membrane permeases belong to the ATP-binding cassette (ABC) 
family of transporters. The multimeric complex of proteins includes a dimer of FepC 
(Pierce 1986), which contains the ATP binding domain. FepD (Ozenberger 1987, 
Chenault 1991) FepC and FepG (Chenault 1991, Chenault 1992) form hydrophobic 
membrane spanning segments. For Fc, similar functions are performed by FhuD (the 
periplasmic binding protein) and FhuB (hydrophobic membrane spanning 
components) and FhuC (ATP binding unit) (Fecker 1983, Rohrbach 1995, Mademidis
1997). While it has not been reported that FepB binds ferric siderophores other than 
FeEnt, FhuD has been shown to carry several hydroxamate ferric siderophores 
(Koster 1990) including ferric aerobactin and coprogen. Similarly, the inner 
membrane permeases FhuB and FhuC act on these additional ferric siderophores. 
The consortium of FepA, FepB and FepCDG deliver FeEnt into the E. coli
cytoplasm. The release of iron from FeEnt requires the presence of the product of the 
fes gene. Fes is FeEnt esterase (Porra 1972, Langman 1972). The release of iron from 
FeEnt faces the difficulty of overcoming the high affinity between enterobactin and 
Fe3+. Instead, a reduction mechanism is proposed where in the Fe3+ is reduced to Fe2+. 
Fe2+ iron binds enterobactin with much lower affinity. The fes protein cleaves the 
ester bonds of the enterobactin moiety releasing oligomers of DHBS. Some evidence 
exists that the DHBS is recycled for the synthesis of Enterobactin. However, the exact 
process of iron release has not been resolved. The reduction potential of FeEnt is so 
low that it is beyond the scope of known physiological reducing agents (O’Brien 
1971, Cooper 1978). Fes may be involved in this process in addition to its esterase 
functions (Brickman 1992). 
12
Structure of ligand-gated porins – FepA and FhuA 
The tertiary structures of ferric siderophore transporters show several common 
features (Figure 3 and 4). To date, the crystal structures of FepA, FhuA and FecA 
have been solved (Buchanan 1999, Locher 1998, Ferguson 1998, Ferguson 2002).
The C domain of these LGPS forms a β barrel bridging the exterior with the periplasm 
of the bacterium. The barrel consists of 22 antiparallel strands. With 22 strands, the 
barrel is larger than those found in general and specific porins. FepA’s C domain 
forms an elliptical cylinder. The molecule is about 70 Å high, with an elliptical cross 
section of 40 Ǻ x 30 Ǻ. The β strands are anchored in the lipid bilayer by a girdle 
formed by aromatic amino acids. The aromatic amino acids interact with the 
hydrophobic interiors of the bilayer.  On the surface, the strands of the barrel are 
linked by eleven long surface loops. Unlike in specific porins like LamB (Schirmer 
1995), no gating loop is observed in the LGPs. Rather, the loops extend out into the 
extracellular space. They lean towards each other forming a conical vestibule that 
extends about 30 Å above the lipid bilayer interface. Although there is no gating loop 
obstructing the intrusion of the ligand, several lines of evidence indicate that the loops 
exhibit considerable dynamics. 
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FepA backbone FhuA backbone
FepA N domain 
FhuA N domain
Figure 3. The crystal structure of FepA and FhuA. FhuA’s N domain is more compact within the 
barrel in both the vertical and the horizontal dimensions. In the first row, the C-domain of the LGPs is 
represented in grayscale while the N domainof FepA is represented in red and that of FhuA in blue 
(Buchanan 1999, Locher 1998, Ferguson, 1998). 
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FepA surface view FhuA surface view
FepA periplasmic face FhuA periplasmic face
Figure 4. Space-filled representations of the crystal structures of FepA and FhuA. In all the 
figures, the C-domain of the LGPs is represented in grayscale while the N domain of FepA is 
represented in red and that of FhuA in blue (Buchanan 1999, Locher 1998, Ferguson, 1998). 
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Scott et al. (2002) demonstrated in-vivo cross-linking of residues in loop 7 of 
FepA to other OM porins like OmpA (Chen 1980). The authors employed the 
homobifunctional, crosslinker sulfo-EGS (Pierce). Sulfo-EGS acts on secondary 
amines, like in the side chain of lysine. The study also revealed that the binding of 
FeEnt abolished such crosslinking. Upon ligand binding, the extracellular loops 
moved towards each other and enclosed the ferric siderophore. From the length of the 
crosslinker, the authors estimated that loop 7 moved almost 15 Å, in response to 
ligand binding. 
A subsequent study by Ferguson et al. (2002) showed similar translational 
motion in an equivalent loop in FecA. Portions of loop 7 traverses nearly 11 A, while 
that of loop 8 moves nearly 15 A. On the periplasmic side, short β turns connect the β
strands of the barrel. The lumen of the barrel is plugged by the N-domain. This 
globular structure is located inside the barrel (Buchanan 1999, Locher 1998, Ferguson 
1998). The N domain contains two loops NL1 and NL2. These loops extend out along 
side the surface loops. Several interactions anchor the N domain inside the C domain 
(see below). Apart from the structural similarities, LGPs share exhibit several 
functional similarities. Their transport mechanism requires the presence of an inner 
membrane protein complex, TonB-ExbB-ExbD (Bassford 1976, Hantke 1978). TonB 
(Wang 1969, Wang 1971, Frost 1975) is a 230-residue protein residing in the 
cytoplasmic membrane of E. coli (Postle 1978, Wookey 1978, Postle 1983, Evans 
1986). Its N terminus is located in the cytoplasm (Postle 1988, Schoffler 1989, Roof 
1991). ExbB and ExbD are considered necessary to stabilize TonB in the inner 
membrane (Fischer 1989). 
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Binding of FeEnt by FepA
Several studies have examined the binding interaction of FepA and FeEnt in 
detail. Early studies with purified protein demonstrated a very high affinity of 
interaction (Kd ~20 nM, Newton 1997). In vivo, the Kd of FeEnt binding has been 
determined to be as low as 0.2 nM (Newton 1999). When proteins are removed from 
their natural habitat, small differences occur in their binding affinity. However, a 100-
fold difference is rather unusual. This difference emphasizes the fact that in the 
membrane, FepA occurs in quite a different conformation from that in the crystal 
structure. The cross-linking studies and the crystal structures of FecA underscore this 
point. The loops are not static in three-dimensional space. Rather they change 
conformations over time. This process may optimize the binding process. 
An important aspect of the interaction is the biphasic nature of binding. Payne 
et al. (1997) demonstrated this aspect employing fluorescence spectroscopy. The 
authors monitored the adsorption of FeEnt to FepA dissolved in the detergents 
dodecyl maltoside and Triton X-100. Analysis of the binding kinetics revealed a rapid 
initial phase (with rate constant k1 = 1.8 × 10
2 ± 8 × 10 4 s 1) followed by a slower 
second phase of adsorption (rate constant k3 = 2.1 × 10
3 ± 2 × 10 4 s 1). These two 
stages may reflect the presence of two binding sites for FeEnt, B1 and B2. 
Alternatively, they may reflect two different events in the binding interaction. The 
orientation of the loops in the bacterium is probably very different from where the 
crystal structure located them. Rather than sloping towards each other, the loops may 
exist in an open conformation like the spread petals of a flower. In this light, it is 
possible that there is a preliminary weak association with the loops in the open 
conformation. Subsequently, the loops may undergo a conformational change and 
move to enclose the ferric siderophore. The difference in the rates of reverse reactions 
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of these two events may be the reason for the biphasic release of the ferric 
siderophore. 
Some evidence exists to support the former two-site model. The crystal 
structure of FepA showed two closely spaced iron peaks (Buchanan 1999). These two 
peaks are located too closely to each other to represent two ferric siderophores. 
Rather, they presumably represent the twin binding sites predicted by the kinetic 
model. Using a site-directed mutagenesis approach, Cao et al. identified residues in 
both sites, whose change affected the binding interaction (Cao 2000). The authors 
identified residues Y272, F329 and Y260 as contributors to the binding interaction. 
The former two map to the putative binding site B1 and the latter to B2. The 
substitution of alanine for tyrosine 260 produces a 100-fold decrease in binding 
affinity, the largest reported effect of a single amino acid substitution in FepA. 
In vivo analysis of the dissociation of FeEnt from FepA further supports the 
biphasic nature of the reaction (Annamalai and Jin 2004). A rapid initial phase and a 
slow secondary phase characterized the dissociation reaction. Upon FeEnt binding, 
the fluorescence intensity of fluorescein 5-maleimide (FM) labeled FepA S271C 
decreases. Release of the bound siderophore restores the fluorescence. This enables 
the direct observation of the dissociation process. FepA-S271C was expressed from a 
tonB-strain of E. coli, which renders it incapable of transport. The authors saturated 
FepA-S271C-FM with FeEnt. Subsequently, they monitored the release of FeEnt from 
the labeled protein. E. coli expressing wild type FepA acted as a ‘sink’ for the 
released FeEnt. The release reaction followed a biphasic pattern. The rate constant 
koff1 for the rapid initial release was 0.03/s and the koff2 for the slower second phase 
was 0.003/s. In vivo experiments with radioisotopic FeEnt also reproduced the two 
phases of its release reaction. The loops of FepA and FecA undergo rather large 
18
translations during the binding reaction. The energy required for this motion may be 
provided by the binding of the siderophore. Motion in vivo and in vitro suggests that 
the process is independent of the cellular energy sources. 
Ligand specificity
The search for a structural explanation for the binding affinity originated from 
the chemistry of the ferric siderophore. FepA recognizes the iron center of the ferric 
siderophore (Ecker 1986, Matzanke 1986, Thulasiraman 1998). By comparing the 
binding of a panel of natural and synthetic siderophores, the authors identified several 
facets of the process. The interaction is not stereospecific. The change in the chirality 
of the catechol groups around the iron center did not affect the binding. The catechol 
groups of FeEnt as mentioned earlier, adopts a ∆ configuration around the iron center. 
Ferric enantioenterobactin (FeEnEnt) contains the opposite Λ chirality. Nevertheless, 
FeEnt and FeEnEnt bound with similar affinity to bacteria expressing genomically 
encoded FepA. However, the protein required the presence of an intact iron center. 
Changes to the backbone of the molecule like substitution of a tertiary amine for the 
lactone ring in FeTRENCAM did not affect the binding. Nor did substitution with a 
benzene ring in FeMECAM affect binding. However, any alteration to the catechol 
moieties as occurs in either natural siderophores like agrobactin or in synthetic 
siderophores like TRENCAM derivatives abolished binding. Ferric agrobactin also 
contains a different net negative charge (see above). The change in the iron center 




















− Microcin J25 
Phage
− T5, T1, UC-1, Φ80
Antibiotics
− Albomycin
− Rifamycin CGP 4832
Table 2. Ligands of LGPs, FepA and FhuA.  
In addition to recognizing FeEnt, FepA also serves as the receptor for the 
bacteriocins, colicin B and D (Pugsley 1976). Colicins are toxins secreted by coliform 
bacteria to eliminate other coliforms. The genes encoding colicins are usually carried 
on plasmids called col factors. The colicin operon carries the activity gene named 
cXa, X indicating the particular colicin. The operon also includes the immunity gene, 
cXi. The presence of the latter’s gene product protects the colicin secreting bacterium 
from the toxin. Colicins function in a variety of ways to kill bacteria.  Colicin B 
belongs to a class of colicins called pore forming colicins. The C terminal domain of 
the colicin kills bacterium by forming pores in the cytoplasmic membrane of the 
target cell. The resultant loss of proton motive force presumably kills the cell. The 
interaction of FepA with these large proteins presumably involves larger surface areas 
of contact than with the siderophores. However, common determinants have been 
found in FepA for these two processes. Payne et al. (1997) demonstrated the in vivo 
competition for binding between the colicin B and FeEnt. Further, colicin B shares the 
biphasic binding kinetics of FeEnt. In addition to binding, for their transport, colicins 
B and D also share components of FepA with FeEnt (see below).  
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The elucidation of the proteinic basis of the binding started from a study of the 
ferric siderophore chemistry. The two prominent features of the complex are its 
negative charge and its aromaticity. This led to the postulate that the binding site must 
complement the chemistry of the ligand. The negative charge prompted the search for 
basic residues in experiments that preceded the crystal structure of FepA (Newton 
1997). At neutral pH, the positive charge of the basic amino acids lysine, arginine and 
histidine will complement the siderophores negative charge. 
A comparison of the sequence of FepA receptors from different gram-negative 
bacteria showed conserved arginines between amino acids 255 and 336. Double 
mutagenesis of Arg 286 and Arg316 to alanine increased the Kd of binding 80-fold. 
Single mutagenesis caused little change in binding affinity. This underscores the
importance of the chemical nature of the amino acids rather than their contribution to 
local secondary structure. Their location in the interior of the barrel, just below the 
extracellular loops favors their assignment as residues participating in the B2 binding 
site. 
Fluorescence spectroscopy with FepA carrying two mutations in its B2 amino 
acids (Y260A and R316A) supported this notion. The authors monitored the kinetics 
of binding of FeEnt to FepA Y260A E280C-Fl R316 by recording the change in 
fluorescence intensity. In contrast to FeEnt-FepAE280C-Fl interaction, the second 
phase of the biphasic binding was abolished (Cao 2000). The simplest explanation for 
this observation is that mutation of these two residues changed the binding properties 
of B2. R316A also caused more than a 10-fold reduction in the sensitivity to colicin B 
and D. 
Newton et al. (1999) also adopted a different line of approach to the problem. 
The authors used site-directed mutagenesis to investigate the participation of 
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individual surface loops in the process. These experiments preceded the determination 
of the crystal structure of FepA. The authors deleted segments of the FepA 
polypeptide corresponding to the putative loops postulated in a previously proposed 
model of FepA (Murphy 1990). The deletions had differing effects on the binding and 
transport process. However, many of the constructs retained some if not complete 
functionality towards FepA’s ligands, FeEnt, colicins B and D. The deletion of loops 
7 and 8 abolished FepA’s function. However, the constructs remained accessible to 
binding by surface epitope specific antibodies. This suggested that loop 7 and loop 8 
are essential for FepA’s binding function. 
In general, the deletion of long segments from a polypeptide is expected to
cause global disruption of its tertiary structure. So an argument can be made that the 
deletion of the loops altered the global protein configuration and it is this 
disfigurement that caused the observed effects. The accessibility to the monoclonal 
antibodies argues against this supposition. Furthermore, the crystal structure of the 
FecA protein (Ferguson 2002) and the experiments with cross-linking (Scott 2002) 
and justified the prediction that these loops are important in the binding process. Upon 
ligand binding, the corresponding loop 7 and 8 in FecA exhibit large translations and 
enclose the siderophore after the initial binding. The cross-linking studies predict a 
similar translation for loop 7 of FepA. The deletion of loops 7 and 8 of FepA also 
abolished sensitivity to colicin B. 
Three catecholate rings surround the iron center of FeEnt forming a zone of 
aromaticity around the cognate face of the siderophore. This led to the proposition 
that aromatic stacking interactions with FepA may contribute to the binding 
interaction. The search for aromatic amino acids in the central region of FepA 
revealed seven conserved residues. Tyrosine 260 is conserved among FeEnt 
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transporters in gram- negative bacteria. Other residues identified include tyrosine 272 
and phenylalanine 329. Genetic replacement of residues 260 (see above), 272 and 329 
with alanine produced significant drops in the adsorption affinity. FepA F329A bound 
FeEnt with 2-fold less affinity. Double and triple mutagenesis of these residues 
caused synergistic defects in binding. Mutagenesis of these residues also affected the 
transport capabilities of the FepA protein. Y260A and Y272A caused commensurate 
reductions in transport and binding, while F329A caused more than a 20-fold 
impairment of transport, ten times the effect on binding. These results suggest that the 
former 2 tyrosine residues act primarily in ligand binding. The effect of their mutation 
on transport derives from the effect on binding. The latter phenylalanine participates 
in the transport process. 
The above studies identified some of the aromatic and basic determinants of 
binding. It is noteworthy that some of the residues like F329, although located at the 
extremities of the surface loops affected transport more than binding. The crystal 
structure of FepA also shows additional aromatic residues, mainly tyrosines in the 
outer reaches of the surface loops. Several of these tyrosines are conserved among 
FeEnt and other ferric siderophore transporters (see below). Based upon sequence 
comparison and exposure in the crystal structure, we selected nine tyrosines and one 
tryptophan in the polypeptide for further investigation (see below). 
Transport of FeEnt by FepA
Despite intense scrutiny, the transport mechanism of FepA has not yet been 
fully resolved. Several experiments have addressed this problem with varying results. 
Some of these experiments focused on the identification of segments or even domains 
important for the transport function. Armstrong et al. (1990) generated segmental 
deletions in frame in the FepA polypeptide using restriction enzymes. They also 
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inserted linker sequences encoding the peptide Leu-Glu, after specific residues in the 
polypeptide sequence. The authors analyzed the phenotypes of these mutant 
constructs. The authors used susceptibility to proteinase K to check localization of the 
proteins. Several of the constructs localized to the OM despite lacking large portions 
of their polypeptides. A derivative of FepA lacking 87 internal residues close to the N 
terminus was unable to transport FeEnt.  The deletion named H261 stretched from 
residue 55 to residue 142. The mature protein lacked the latter two-thirds of the N 
domain. The construct also conferred less than 5% sensitivity to Colicins B and D 
compared to the wild-type protein. The insertion of Leu-Glu peptides after residue 
204 or 635 affected only colicin sensitivity. The mature proteins transported FeEnt at 
almost wild-type levels. These studies preceded the elucidation of the crystal structure 
of the LGPs.
Surface loops in FepA transport
The surface loops of FepA also play important roles in the transport process in 
addition to their role in binding. The fact that the effects of their deletion on transport 
did not always derive from the effects on binding supports this conclusion (Newton 
1999). Newton et al. (1999) identified these ‘class i and ii mutants’ by comparing the 
change in the Kd of binding and the Km of transport. These mutants had greater effects 
on transport than on binding. Class ii mutants had such large effects on the Km that the 
authors had to extend uptake times up to an hour to measure the slow rates of 
transport. Class i includes loops 3, 4, 5 and 9. Loops 2, 10 and 11 showed class ii 
effects. As mentioned earlier, alanine mutagenesis identified F329 as one of the 
residues important for the transport process (Cao 2000). F329 lies in a segment of the 
polypeptide that was not mapped in the crystal structure (from residues 324 to 334). 
However, its probable location is in the outer reaches of surface loop 5. Despite this 
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location, the amino acid plays a greater role in transport than in binding. This 
underscores the point that the transport of the ferric siderophore employs components 
from all parts of FepA including the surface loops. 
The N domain in FepA transport
Scott et al. (2001) utilized site directed mutagenesis to excise the N domain of 
FepA. The resultant construct, Fepβ bound and transported FeEnt (Scott 2001). The 
Kd of binding and Km of transport were similar to wild type FepA. However, the 
capacity of binding and the maximum velocity of the transport were severely reduced. 
The latter two parameters reflect the fraction of functional protein molecules on the 
surface of the bacterium. The mutations also affected colicin B and D sensitivity. 
FepΒ required the presence of TonB in order to accomplish these functions. A similar 
result was obtained with FhuA (Braun 1999, Scott 2001). In addition to the deletion of 
the N domain, the authors also constructed chimerical proteins, wherein they 
genetically exchanged the N domains of FepA and FhuA to generate FhuNFepβ and 
FepNFhuβ. The chimeras behaved similar to the deletions. The results implied that the 
N domains of LGPs serve secondary roles in their binding and transport functions. 
The surface loops discriminate between the siderophores FeEnt and Fc. They are able 
to transport without their own N domain or even with a different N domain. They are 
also able to interact directly with TonB. The N domains of the LGPs have no 
specificity for their cognate siderophores. The chief role of the N domain is to interact 
with the surface loops to enable them to adopt functional conformations. This could 
explain the low fraction of competent proteins in the deletions and the chimeras. 
A subsequent investigation (Vakharia 2002) contradicted these findings. The 
deletion of the N domain of FepA rendered it nonfunctional in their host strain, E. coli
KP1411. The mutation abolished colicin B sensitivity. However, their constructs 
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rendered colicin B susceptibility to E. coli RWB18-60 (F- leu proC trp thi rpsL recA 
entA fepA). The strain of E. coli used by Scott et al. (2001) was KDF541 (F- leu proC 
trp thi rpsL recA entA fepA fhuA cir). KDF541 is derived from RWB18-60. They 
contain the same mutation in the FepA gene. The mutation is so located that the gene 
could still express 363 residues of the protein. The resultant fragment, if expressed 
contains the complete N domain, which may in turn complement Fepβ. The low 
efficiency of this complementation may explain the lower capacity of binding and the 
lower Vmax of transport. A similar explanation may hold true for FhuA. Braun et al. 
(2003) cloned the isolated N domain and the C domain in tandem and expressed these 
fragments in the fhuA strain of E. coli, BL21. They employed formaldehyde 
crosslinking to conclude that the separately expressed N domain incorporated itself 
into the C domain in the OM. They also used cysteine substitutions on each domain to 
obtain similar evidence for incorporation by observing inter-domain disulfide bond 
formation. Although these results suggest that close proximity between the isolated 
domains happens, they do not prove that the domain interaction results in native 
protein-like conformation. The interactions observed may take place during protein 
folding or assembly into the OM. The requirement for signal sequences on both the 
individual gene fragments suggests that this process happens outside the cytoplasm. 
Nevertheless, the role of the fragment containing the N domain in Fepβ expressing 
clones needs to be resolved.  
The possibility of complementation between the chromosomal fragment and 
Fepβ or Fhuβ necessitated the development of E. coli strains with precise deletions of 
FepA and FhuA structural genes (see below). To clarify the functionality of the 
different FepA and FhuA constructs (Scott 2001), I examined the phenotype they 
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conferred on fepA- and fhuA- bacteria. I also repeated some of the experiments 
reported earlier (Vakharia 2002, Braun 2003).
The role of the N domain in toto needs further investigation. However, 
evidence attributing important functions to parts of the N domain has been obtained. 
A random mutagenesis approach identified residues in the N domain that affected 
both FeEnt transport and colicin binding and sensitivity (Barnard 2001). The study 
identified three regions in the N domain. These include the tonB box (see below), the 
loops and a cluster near the barrel wall. The three regions house one or more residues 
that affect the protein function. The tonB box residues are Ile14 and Val16. Gly64 is 
located in loop NL1 and Arg105 belongs to NL2 (see above). The cluster near the 
barrel wall included residues Arginines 75 and 126 and glycines 127, 139 and 140. 
Although the random mutagenesis identified these amino acids, the replacement of 
amino acids with residues other than alanine poses a potential problem. For example, 
the substitution of a proline for arginine105 may cause large-scale differences in the 
conformation of the protein. Similar effects need to be demonstrated with site-directed 
mutagenesis of the said residues to alanine. Further more, the authors subjected a part 
of the fepA gene coding for the N domain to random mutagenesis. They exchanged 
the segment with that of the wild-type fepA gene on a plasmid, transformed a fepA-
strain of E. coli and selected the resultant clones for resistance to colicin B. The 
authors then sequenced the N domain portion of the gene and identified these 
mutations. Although it is a small possibility with the short sequence of the plasmid 
encoded genes, the colicin B screening may have selected for other mutations located 
in the rest of the fepA gene. Sequencing the entire fepA gene would have excluded this 
confounding possibility. Using site–directed mutagenesis, Chakraborty et al. (2003) 
changed arginines in the N domain that formed part of a lock-box with glutamates of 
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the C domain. These changes had little effect on binding but had moderate to severe 
effects on the transport functions. 
The N domain of FepA contains two loops NL1 and NL2. The loops connect 
the strand Nβ1 with Nβ4 (loop NL1) and the strand Nβ4 with Nβ5 (loop NL2). Loop 
NL1 contains an additional antiparallel β-hairpin (Nβ2, Nβ3). Both loops extend from 
the center of the pore toward the extracellular loops of the barrel, at heights of ~17 Å 
(NL1) and ~19 Å (NL2) above the bilayer interface. The loops are well placed to 
interact with the ligand, FeEnt during its binding and transport. In the crystal 
structure, the loops exist in close proximity to the electron density considered to be 
the iron atom of FeEnt. Therefore, these loops were dubbed as the sensor loops. In 
order to determine their role in the protein’s function, portions of these loops were 
deleted and the binding and transport properties of the resultant constructs were 
examined (see below).
TonB and ferric siderophore transporters 
One of the intriguing aspects of LGP function is their dependence on TonB 
and energy. Almost all functions of LGPs require TonB. The interaction of the phage 
T5 with FhuA is a known exception (Hantke 1978). The binding of ligand happens 
independently of TonB. FepA expressed in functionally tonB- strains binds FeEnt just 
like tonB+ strains. However, the absence of the protein abrogates transport. Questions 
remain about the mechanism of tonB action. Does TonB bind LGPs? If it does, what 
are the binding sites? How does this intermembrane communication happen? 
Numerous studies have suggested the direct interaction of TonB with LGPs 
(Heller 1988, Gunter 1990). One of the models proposed for the interaction involves 
the cycling of TonB between the outer and inner membrane of E. coli (Letain 1997). 
The authors of this model observed that TonB fractionated with both the outer and 
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inner membranes of E. coli in sucrose density gradient separations. Another 
methodology assessed the accessibility of the TonB N terminus to labeling with dyes 
(Larsen 2003). The authors labeled a cysteine mutant of TonB with the dye, Oregon 
green. Oregon green freely enters the periplasm (Yan 1993), but does not penetrate 
the cytoplasmic membrane. By making the cysteine substitution close to the N 
terminus of the protein, the authors concluded that this labeling reflected exposure of 
the target cysteine and thereby the N terminus to the periplasm. The N terminus of 
TonB is normally located in the cytoplasm. The authors postulate that the protein 
cycles between membranes and delivers the transport signal to ligand-gated porins. 
However, it remains doubtful whether this cycling can occur fast enough for the 10-
fold fewer tonB molecules to enable transport by FepA proteins. It is unclear whether 
TonB or FepA or both have sufficient lateral mobility in their membranes to sustain 
the process as the model envisages. The exterior surface of the outer leaflet of the OM 
bilayer is covered by the contiguous lipopolyscaccharide (LPS). Since the LGPs 
project 30 to 40 Ǻ above the lipid bilayer, they would have to negotiate their way 
laterally through not only the lipid bilayer but also the LPS. In other words, both the 
LPS and the membrane bilayer would need to be fluid structures. It is also noteworthy 
that no membrane rafts serving as protein-protein interfaces have been reported for 
bacterial inner and OMs. The relative localization of tonB and FepA molecules on the 
bacterial membrane structure is as yet unresolved. Questions remain whether these 
molecules are spread diffusely throughout the bacterial membrane or localized to 
specific loci like Bayer’s zones of adhesion (Bayer 1991). The later location can 
conceivably provide a ready interface for interaction between the LGPs and TonB.  
Other investigators have employed different approaches to study the 
interaction between the LGPs and TonB. Skare et al. (1993) used formaldehyde 
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crosslinking to observe complexes between FepA and TonB. Ogierman et al. (2003) 
observed disulfide formation in vivo between introduced cysteines in TonB and FecA. 
The cysteines were substituted for residues in the tonB box of FecA (D80C, A81C, 
L82C, T83C and V84C) and the C domain of TonB (Q160C, Q162C and Y163C). 
Paired combinations of these mutations, one on each protein, showed in vivo disulfide 
formation between the cysteine mutants of TonB and FecA. The authors also 
performed formaldehyde cross-linking between the two proteins. The cross-linking 
studies suggest that the C domain of TonB comes in close proximity with the LGPs. 
The proteins may therefore interact with one another and the LGPs transport their 
ligands across the OM. At what stage of the uptake after binding, this interaction 
happens and how it helps transport, remains unsolved. TonB has also been suggested 
as the energy transducer for transport. However, it has not yet been discovered as to 
how this supposed energy transduction takes place. 
The N domain– where art thou?
The crystal structures of LGPs like FepA and FhuA show their N domain 
completely filling the β barrel formed by the C domains. This location of the N 
domain within the C domain necessitates a change in its own conformation in order to 
allow transport of the cognate ligands. We can construe at least three different models 
to explain the transport process (Klebba 2004). The entire N domain may efflux out of 
the channel into the periplasm (the concerted transport model). Alternatively, a 
variation of the concerted model is that the N domain may incur a compaction inside 
the barrel. Both these possibilities predict the creation of a tunnel in the protein 
linking the surface with the periplasm. A third possibility is that the siderophore may 
slide along successive portions of the barrel and the N domain (sequential). This 
model envisages the creation of serial binding pockets for the siderophore along the 
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length of the protein. The latter two models also involve conformational changes 
within the N domain. 
Each postulate has its own merits and demerits. There are 46 direct or water 
mediated hydrogen bonds tethering the N domain to the β strands of the C domain. 
Moreover, there are 17 interactions between the N domain and the extracellular loops 
(Buchanan 1999). These hydrogen bonds may seem to be an energetic barrier for the 
efflux of the N domain. However, the extruded N domain will enter the aqueous 
periplasm. This should enable the reformation of these hydrogen bonds with water. 
Therefore, the hydrogen bonds by themselves do not exclude the efflux model. 
Usher et al. (2001) reported that the isolated N domain of FepA is expressed 
in the periplasm of the host strain in a partially denatured form They found that the 
isolated N domain can bind FeEnt in vitro with 1000-fold less affinity than the whole 
protein. The authors postulated that the denaturation of the N domain in the periplasm 
may help to release the bound ferric siderophore. However, the return of the N 
domain into the barrel would then involve its refolding as seen in the crystal structure. 
TonB may be involved in this process. The physiological function of the LGPs is the 
internalization of small ligands like ferric siderophores. Additionally, they support the 
transport of much larger entities like domains of proteins and phages. The transport of 
ferric siderophores does not require the entire diameter of the barrel. 
The concerted efflux model is also the most suitable for the transport of 
domains of the macromolecules such as colicins. The concerted compaction model 
would also involve a similar rearrangement of some of the hydrogen bonds. A 
relevant consideration here is the volume available in the barrel. β-barrels are stable 
structures and they are not expected to undergo large scale distortions in their 
configurations. The calculated exterior volume of the elliptical cylinder formed by the 
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C domain is around 15, 000 Å3 (ABE Volume Calculator Page, S.D. Filip To, 
http://www.abe.msstate.edu/~fto/tools/vol/index.html). If a bridging tunnel arises in 
the interior of the barrel, it would need to be sufficiently large to accommodate FeEnt, 
the radius of whose iron center is about 4.5 Å. Therefore, a cylinder of about 9 Å 
cross -sectional diameter and around 70 Å high is required. The volume of the space 
will be around 4450 Å3. It is not clear if the N domain can compact itself to less than 
two-thirds of the available volume. This consideration favors the next model. 
The sequential model is perhaps the least attractive model. The transport 
process may happen in one of two ways. As the ferric siderophore slides along the 
channel, successive binding pockets are formed with increasing affinity for the ligand. 
The lowermost pocket may equilibrate with the periplasmic aqueous medium. 
However, this would imply that this pocket is in some way destabilized in order to 
release the ferric siderophore. TonB and/or energy may drive this process. 
Alternatively, the creation of each high affinity site may be succeeded by its own 
destabilization and the simultaneous creation of the successor site. At the lowermost 
site, this would enable the siderophore to enter the periplasm. 
The concerted efflux of the N domain is relatively more amenable to 
experimental investigation. If the N domain exits out of the barrel and enters the 
periplasmic space, it implies that it will be physically accessible in the periplasm. I 
adopted two different strategies that could potentially detect the N domain in the 
periplasm. The first strategy involved the use of the Tobacco Etch Virus protease 
(TEV protease). The analytical utility of TEV protease (Dougherty 1988) in protein 
chemistry stems from its having a relatively unique target amino acid sequence, 
ENLYFQ*G. The introduction of this sequence into surface exposed loci of cellular 
proteins renders these molecules susceptible to proteolysis by the cysteine protease 
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(Target directed proteolysis, coined by Micheal Ehrmann, School of Biosciences, 
Cardiff University, Cardiff, UK). The experimental design involved the introduction 
of the protease recognition site in the N domain of the receptor protein by site-
directed mutagenesis. The protease was introduced into the periplasm of the bacteria. 
Transport through the receptor was induced by adding the cognate ferric siderophore. 
If the N domain travels outside the periplasm, then the protease will gain access to the 
target sequence and cleave the receptor into two fragments, which can be observed 
with standard protein detection techniques. Accordingly, I engineered protease 
recognition sites in the N domain of FhuA. 
The rationale behind my choice of FhuA and not FepA stemmed from two 
observations. One of them, which still holds true is the nature of the domain in FhuA 
and FepA. In FhuA, the globular N domain is more compact inside the barrel. On the 
other hand, FepA’s N domain fills out its barrel (Buchanan 1999, Locher 1998, 
Ferguson 1998). I felt that this difference might cause changes to FepA’s N domain to 
be more disruptive than FhuA’s domain. The other observation was that when the N 
domains of the proteins were exchanged between FepA and FhuA, the FhuA β barrel 
– FepA N domain (HPEB) chimera functioned better than the reverse combination 
(Scott 2001). This suggested that changes in the N domain of FhuA and even its 
complete replacement leaves a more functional Fc transporter than similar 
manipulations of FepA does a FeEnt transporter. This conclusion has since been 
questioned by subsequent investigations (Vakharia 2002, Braun 2003) (see also 
below).  
I selected sites based on their surface inaccessibility in the crystal structure 
and on the local amino acid sequence (Coulton 1986) to minimize structural and 
chemical perturbations to the protein. They are located at three levels in the FhuA N 
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domain; near the periplasmic opening, FhuA136-142, and one each on the two N 
domain loops, FhuA71-77 and FhuA113-119, the former on the loop away from the 
hinge and the latter at the highest point on the side of the hinge between the N- and 
the C- domains (Figure 5). Using biochemical and microbiological techniques, I 
attempted to characterize the orientation of the N domain during the FhuA’s transport 
cycle. 
For my experiments, I used both purified as well as coexpressed TEV 
protease. We obtained purified recombinant TEV protease (rTEV protease) from 
Invitrogen. 1 unit of rTEV protease cleaves >95% of 3 µg control substrate in 1 hr at 
30°C. In the past, proteolytic specificity has been harnessed to map the topology of a 
protein, particularly membrane proteins (protease accessibility assay, Murphy 1992). 
The capability has been also been expanded to the analysis of proteins by 
coexpression in vivo (Mondigler 1996). Here I attempt to extend the technique further 
to analyze the chronological disposition of a dynamic domain of a transport protein. 
The second strategy that I employed to investigate the disposition of the N 
domain involved fluorophore labeling. Cao et al. described the protocols for 
specifically labeling FepA with fluorophores in vivo (2003). The authors introduced 
cysteines in the polypeptide by site-directed substitution mutagenesis. The cysteines 
were then labeled with sulfhydryl reactive flurochromes including FM and Alexa 
Fluor® 680 C5-maleimide.   The maleimidyl moiety specifically targets cysteines on 
proteins. In the oxidative environments in the periplasm and the cell exterior, the 
cysteines on proteins usually form cystines with each other. As a result, unbonded 
cysteines are rare in secreted proteins. The paucity of reduced cysteines enables the 
specific labeling of introduced cysteines in vivo. 
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The experimental design in this case involved the introduction of cysteines by 
site-directed substitution mutagenesis in different parts of the N domain. Some of 
these loci are surrounded by the barrel in the crystal structure, while others are 
expected to be exposed either to the cell surface or to the periplasm. I then assessed 
the accessibility of these cysteines to labeling by fluorophores. By comparing their 
susceptibility to labeling with their location in the crystal structure, I hoped to map the 
location of these regions of the protein during the transport cycle. If residues that are 
hidden in the crystal structure can be made susceptible to labeling by inducing 
transport, then it follows that these regions undergo conformational changes to expose 
the cysteines. In this manner, I hoped to characterize the chronological disposition of 
the N domain during protein function. 
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Figure 5. Location of FhuA TEV site mutations. The crystal structure of the FhuA backbone is 
depicted in grayscale. On the left is the whole protein and on the right is the N-domain. The amino 
acids substituted for the TEV sites are depicted in space-filled fashion, amino acids 71-77 (blue), 113-




Bacterial strains, plasmids and culture conditions: 
Bacteria and plasmids used in this study are listed in the tables below (tables 3 
and 4). Unless otherwise mentioned, all the bacterial strains are derivatives of E. coli
K12. Unless otherwise stated, bacteria were grown in Luria Bertani (LB) medium 
(Miller 1972) at 37°C. Bacteria expressing the pUC18, pCC1 or pMER1 plasmids 
grew poorly in plain LB medium (LB is frequently rich in lactose and induces 
debilitating protein expression): therefore, I added 1% glucose (catabolite repressor) 
to the culture. Where required, I used terrific broth, tryptone and nutrient broth.
For subculture, I used a variety of defined media including MOPS medium 
(Neidhardt 1974) with or without zinc and copper, T medium, minimal medium A and 
minimal medium 9. Unless otherwise stated, the antibiotics ampicillin (100 µg/ml), 
streptomycin (100 µg/ ml) and chloramphenicol (20 µg/ml) were added as required. 
All antibiotics were purchased from Sigma. Glucose (0.4%) or acetate (0.25%) was 
used as carbon sources, as dictated by the nature of the plasmid promoters. To induce 
protein expression from specific promoters, I added inducers including 0.2% 
arabinose (for ara promoter) and 10 µM IPTG (for lacZ or lacIq) respectively to 
exponentially growing cultures. When required, I used the sulfhydryl reducing agents 
1 mM of cysteine, 2-mercaptoethanol, dithiothreitol (DTT) or dimercaprol (BAL) 
(SIGMA).  
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Strain Relevant genotype Reference or source
AB2847 aroB tsx malT thi Braun 1978
BN1071 F-  thi  entA  pro trp  rpsL Klebba 1982
CC118 F- ∆(ara-leu)7697 araD 139 ∆lacX74 galE galK
∆phoA20 thi rpsE rpoB argE (Am) recA1appR1
Manoil 1985
KDF541 F- leu pro trp thi rpsL  recA entA fepA fhuA cir Rutz 1992 
KDF571 KDF541 tonB Rutz 1992 
KDL118 CC118 fepA Murphy 1989
KS272 F- ∆lacX74 galE galK thi 
rpsL(strA)∆PhoA(PvuII)
Strauch 1998
MB 97 AB2847 fhuA Braun 2003
OKN3 BN1071 fepA Salete Newton
OKN73 MB97 fepA This study
SF120 KS272 ptr-32::ΩCmrdegP41(∆PstI-Kanr)∆ompT Meerman 1994
SF130 SF120 rpoH 15 (minitet) Meerman 1994
Table 3. List of strains used in this study.
Plasmid name Relevant genotype/phenotype Reference
pCC1 Ptac male::TEV protease lacIq Cmr Ehrmann, M
pfepNfhuβ pHSG575 fepA 1-152::fhuA160-723 Scott 2001
pfepβ pHSG575 fepA (∆17-150) ,,
pfhuNfepβ pHSG575 fhuA1-155::fepA149-724 ,,
pfhuβ pHSG575 fhuA (∆5-160) ,,






pFTPc pHSG575 fepA-TEV site-PhoA fusion 
Cmr full fepA promoter
This study
pHP751 pT7-5 cma cmi Pilsl 1993
pITS11TEV site 113-119 fhuA113-119ENLYFQG This study
pITS11TEV site 136-142 fhuA136-142ENLYFQG ,,
pITS11TEV site 71-77 fhuA71-77ENLYFQG ,,
pITS11 full promoter-fhuA Scott 2001
pITS23 pHSG575 fepA (full fepA promoter) Scott 2001
pITS449 pUC18fepA (No -35 region of 
fepA’s promoter)
Armstrong 1990
pMER1 pBAD22 malE-TEVsite-phoA Apr Ehrmann, M
pUC18fepN pUC18fepA (1-150) Scott, DC
pUC18fhuA fhuA Scott, DC
pUC18fhuATEV site 113-119 fhuA113-119ENLYFQG ,,
pUC18fhuATEV site 136-142 fhuA136-142ENLYFQG ,,
pUC18fhuATEV site 71-77 fhuA71-77ENLYFQG This study
Table 4. List of plasmids, their relevant genotypes and their sources/references. 
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Site-directed mutagenesis 
The mutations were engineered either by Kunkel’s M13 mutagenesis (Kunkel 
1985) or by Quikchange® site directed mutagenesis method (Stratagene, San Diego, 
CA). Kunkel’s mutagenesis was used to generate the alanine substitutions of surface 
residues in pITS 449 (Rutz 1992). Plasmid pITS449 (Plasmid iron transporter system)
is a derivative of pUC 18 (a high copy plasmid vector, Yanisch-perron 1985) with the 
fepA gene cloned into the SmaI site of the vector (Armstrong 1990). The gene is under 
the control of its natural fur regulated promoter. However, only one (-10) of the two 
promoter regions, located upstream of the structural gene, is cloned into the plasmid. 
The mutation was then transferred to pITS23 by restriction fragment exchange with 
the endonucleases KpnI and SstI (Invitrogen). Mutations W101A, Y217A and Y540A 
were directly engineered on pITS23 using the Quikchange kit. All the mutations were 
confirmed by double stranded sequencing using the Alf Express sequencer 
(Amersham Pharmacia), and appropriate CY-5 labeled oligonucleotide primers.
I introduced the TEV-protease target sites in FhuA (Table) by site-directed 
mutagenesis (Quikchange, Stratagene). I substituted 7 amino acid segments of the 
polypeptide with the TEV recognition sequence, ENLYFQ*G. The mutant FhuA 
proteins were cloned into the plasmid vectors, either the high copy pUC18 or the low 
copy pHSG575. FhuA-TEV site constructs were expressed in either KDF541 (FepA-
FhuA-) or MB97 (fhuA) or OKN73 (fhuAfepA). 
Protein detection 
Bacteria were grown overnight in LB broth, and subcultured into iron deficient 
MOPS minimal medium (containing glucose and other nutritional supplements, 
Neidhardt 1974) for 5.5 to 6.5 hours at 37°C with vigorous aeration. For strains that 
failed to grow in MOPS medium, I used T medium or iron poor nutrient broth. For 
40
non-iron regulated proteins, bacteria were grown in LB broth or other rich media. 
Volumes corresponding to 5 x 108 bacteria were centrifuged at 17,000 x g and 
resuspended in 100 µl of sample buffer (60 mM Tris, pH 6.8, 10% glycerol, 2% 
sodium dodecyl sulfate (SDS), 3% 2-mercaptoethanol), and boiled for 3 min to 
achieve complete cell lysis. 2-mercaptoethanol was omitted for nonreducing 
electrophoresis. After centrifugation at 10,000 x g for 3 min to pellet cell debris, 20 µl 
samples of the whole cell lysates were loaded onto a 10% SDS polyacrylamide gel 
(SDS-PAGE, Laemmli 1970). The sample was electrophoresed at room temperature 
for about 1.5 hours and electro-eluted on to nitrocellulose membranes. 
For nondenaturing electrophoresis, the samples were not boiled and 
electrophoresed at room temperature or at 4°C. Western immuno blots were 
performed using specific antibody solutions and developed with 125I-Protein A. The 
nitrocellulose was exposed to a phosphor imaging screen overnight. The radioactivity 
was quantitated by phosphor imaging (Molecular Dynamics). Alternatively, the blots 
were developed colorimetrically with Nitroblue tetrazolium and bromochloroindolyl 
phosphate (NBT/BCIP). In some experiments, the gel was also stained with 
coomassie blue (Fairbanks 1971) for observing the protein bands.
Siderophore nutrition assay
Bacteria were grown in LB medium until they reached an Abs600 ~ 0.5-1.0 
(exponential phase of growth). Alternatively, I grew bacteria in iron-poor nutrient 
broth or iron-free MOPS medium. A100 µl sample of the bacterial culture was plated 
with 3 ml of soft nutrient top agar (low iron medium) containing 100 µM of the iron 
chelator, apoferrichrome A and the relevant antibiotics. Alternatively, I used 100 µM 
bipyridyl A as the chelator. A sterile paper disc (Becton Dickinson and company, 
France) was placed in the center of the solidified top agar and 10 µl of 50 µM ferric 
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siderophore was added to the center of the disc. The plates were incubated overnight 
at 37°C. The results were expressed as the diameter of the zone of visible growth in 
mm, around the paper disk.
Siderophore binding
Bacteria expressing wild-type or mutant ligand-gated porins were grown 
overnight in LB and subcultured into MOPS and allowed to grow for 5.5 to 6.5 hours 
at 37°C with vigorous aeration and then placed on ice. 59Fe-siderophore was prepared 
with a specific activity of 150-400 cpm/pmol and purified by column 
chromatography. I carried out the binding reaction (Newton 1999) at 0°C to prevent 
the uptake of bound ferric siderophore. A 100 µl aliquot of the ice cold culture (~5 x 
107 bacteria) was taken in a 50 ml test tube and 10 ml of ice cold MOPS medium 
containing the different concentrations of 59ferric siderophore was poured into the 
tube to achieve rapid and thorough mixing. The tubes were incubated on ice for 1 min 
and the mixture filtered through 0.45 µm and washed with 10 ml of 0.9 % LiCl (aq). 
The bound radioactivity was counted using in a Packard Cobra gamma counter. I 
tested bacteria not expressing the proteins of interest as negative control and 
subtracted the values obtained from those of the test strains, to exclude non-specific 
adsorption. The experiments were generally done in triplicate for each concentration 
of ferric siderophore used. Aliquots of the bacterial culture were saved for 
determining the level of protein expression for each mutant strain in the binding 
experiment. The Kd and capacity of binding of wild type and mutant receptors were 
determined using the one site bound versus free equation in Grafit 5.0.9 (Erithacus).
Siderophore transport 
Bacteria expression the receptor proteins were grown overnight in LB and 
subcultured into MOPS and allowed to grow for 5.5 to 6.5 hours at 37°C with 
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vigorous aeration. 59FeEnt was prepared with a specific activity of 200-400 cpm/pmol 
and purified by column chromatography. All the transport procedures (Newton 1999) 
were performed at 37°C. A 100 µl aliquot (~ 5 x 107 bacteria) of the bacterial culture 
was taken in a 50 ml test tube and 10 ml of MOPS medium containing the different 
concentrations of 59FeEnt was poured into the tube. After incubation, the transport 
reaction was quenched with a 100-fold excess of non-radioactive ferric siderophore. 
Reactions with very high concentrations of 59Fe-siderophore (> 100 nM) were not 
quenched because of the extremely large amounts required to achieve a 100-fold 
excess of non-radioactive ligand.  The mixture was then filtered through 0.45 µM 
nitrocellulose filters and washed with ice cold 0.9 % LiCl in water. The bound 
radioactivity (in cpm) was counted using a Packard Cobra gamma counter.  Negative 
controls were also tested when high concentrations of FeEnt were used for the low 
affinity mutants. The experiments were generally done in triplicate for each 
concentration of ferric siderophore. Aliquots of the bacterial culture were saved for 
determining the level of protein expression for each strain in the transport experiment. 
The initial transport rate was calculated by measuring the difference in the bound cpm 
between two independent measurements, one incubated for 5 sec and the other for 15 
sec, for each concentration of ferric siderophore. The Km and the Vmax of transport 
were determined from these 10 sec uptake rates using the Enzyme Kinetics equation 
in Grafit 5.0.9 (Erithracus).  For mutants with lower uptake capabilities, the kinetic 
parameters were calculated by measuring the uptake over longer periods of time. 
Colicin killing assay 
Bacteria were grown overnight in LB medium. A 100 µl sample of the culture 
was plated on LB agar with 3 ml of tryptone top agar containing the relevant 
antibiotics. Serial dilutions of Colicins B and D were made fresh in LB and applied on 
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to the plate using a clonemaster (Immusine). The plates were incubated at 37°C 
overnight. The susceptibility to colicin killing (Cao 2000) was expressed in arbitrary 
titration units, defined as the reciprocal of the highest dilution of colicin that caused a 
clearing of the bacterial lawn. The data was tabulated as the ratio of the mutant titer to 
the wild type titer in percentage units. 
Competition between ferric catecholates 
Bacteria expressing FepA were grown overnight in LB and subcultured into 
MOPS and allowed to grow for 5.5 to 6.5 hours at 37°C with vigorous aeration. 
59FeEnt was prepared as mentioned above. The bacterial suspension was incubated 
with premixed 59FeEnt and varying concentrations of the competitor. All 
manipulations were performed on ice. The experiments were done in triplicate for 
each mixture of competitor with 1 nM 59FeEnt. The cells were then collected by 
filtration through nitrocellulose and washed with 0.9 % lithium chloride to remove 
unbound ligand. The bound radioactivity (in cpm) was counted using a Packard Cobra 
gamma counter.  KDF541 was also tested as negative control and the values 
subtracted from those of the test strains, to exclude non-specific adsorption. 
Periplasmic incorporation of TEV protease 
Periplasmic incorporation of the TEV protease was performed by the 
methodology described by Brass (Brass, Methods in Enzymology. Vol. 125, 289-
302). Bacteria from an overnight culture were subcultured into MOPS medium and 
grown until the culture reached an Abs600 of 0.5 – 0.7. A total of 1 x 109 cells were 
pelleted down by centrifuging at 10000 to 12000 x g for 2-5 min in a 1.5 ml 
microcentrifuge tube. The cell pellet was washed first with 1 ml of 100 mM Tris -
HCl, pH 7.5 and then with 1 ml of 100 mM potassium phosphate buffer, pH 7.5 at 
room temperature. The cells are then suspended in 50 µl of ice cold 100 mM Tris-
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HCl, pH 7.5 containing 300 mM CaCl2 and variable amounts of TEV protease 
(Invitrogen), transferred to 110x10 mm test tubes and shaken vigorously on ice for 30 
min using a reciprocal shaker. Alternatively, the bacteria were permeablized with 
low-calcium high-sucrose buffers (Zgurskya 1999). The cells are then washed with 
0.9% NaCl at room temperature once or twice. The cell pellet is then resuspended in 1 
ml of MOPS medium and retained at RT until use (typically 15 min). 
Periplasmic expression of TEV protease 
Plasmid pCC1 encodes a periplasmically expressed maltose binding protein -
TEV protease fusion. The test substrate used was maltose binding protein – TEV site 
– Alkaline Phosphatase fusion (MBP-TEV site-PhoA), expressed by plasmid pMER1. 
The substrate protein is also expressed in the periplasm. Both pCC1 and pMER1 were 
gifts from Michael Ehrmann. For periplasmic coexpression of TEV protease with its 
targets, I transformed bacteria with plasmids pCC1 and pUC18fhuA (wild type or 
TEV site derivatives) or pMER1 simultaneously. The transformed bacteria were 
grown overnight in LB with glucose and subcultured into MOPS or MMA medium. 
After the culture reached an Abs600 of 0.4, I induced the expression of the TEV 
protease with IPTG. The expression of the control substrate was induced with 
arabinose.  
Proteolysis by incorporated TEV-protease 
After the periplasmic incorporation of the protease, I incubated the bacteria in 
the defined medium (containing antibiotics and sulfhydryl reagents) at 37°C with 
vigorous aeration for 1 to 6 hours. For proteolysis of FhuA targets during the transport 
cycle, I added variable amounts of Fc. In each case, sufficient Fc was added to sustain 
transport by bacteria expressing wild type FhuA (Vmax for KDF541 
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pHSG575fhuA+=87 pmol/109 cells/min) for the entire duration of the experiment. 
Finally, the cells were pelleted and subjected to SDS-PAGE and immunoblotting. 
Proteolysis by co-expressed TEV protease 
Overnight cultures of bacteria were subcultured into defined media. After they 
reached an Abs600 of 0.4, inducers, DTT/BAL and Fc were added as required and the 
culture was further incubated at 30°C or 37°C for 2 to 6 hours. The cells were 
harvested and processed for immunoblots.  
Cloning of FepA-TEV site- PhoA 
The fusion protein was cloned into the low copy plasmid vector, pHSG575 
producing plasmid pFTPc. The fepA gene from pITS23 was amplified with the 
primers, M13 forward primer (Integrated DNA Technologies) and FepA.C.XbaI. The 
latter primer carried an XbaI recognition site. The purified PCR product was digested 
with PstI and XbaI to get insert 1. The TEV site-PhoA segment of pMER1 was 
digested with the enzymes XbaI and SacI to get insert 2. Plasmid pITS23 was 
digested with PstI and SacI to obtain the vector segment. The vector and the 2 inserts 
were ligated with T4 DNA ligase (New England Biolabs) to give pFTPc. The 
expression of the fusion protein is regulated by fepA’s natural promoter. The construct 
was verified by double stranded sequencing. For expression from the high copy 
plasmid vector, I transferred the fepA-TEV site-phoA gene construct to pUC18. I 
amplified the fusion gene from pFTPc by PCR with M13 forward and reverse primers 
(Integrated DNA Technologies). The purified PCR product was digested with MluI 
and SacI to obtain the insert fragment. Plasmid pITS449 (pUC18fepA) was similarly 
digested to obtain the vector fragment. The vector and the insert fragments were 
ligated to get pUCFTPa. However, this clone remains to be verified. 
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Expression of FepA-TEV site-PhoA 
The plasmid pFTPc was transformed into strains OKN3 (fepA-) and KDL118 
(fepA-phoA-). Bacteria were grown overnight in LB medium with the relevant 
antibiotics. They were then subcultured into MOPS medium (OKN3) or T medium 
(KDL118). After the cells reached stationary phase, cell lysates were prepared and 
subjected to western blotting. For detecting FepA, I used murine ascites fluid 
containing monoclonal anti-FepA antibodies, either mab41 (epitope in N domain) or 
mab45 (epitope in C domain). For PhoA, I used rabbit serum containing polyclonal 
anti-PhoA antibodies. 
FM labeling of bacterial proteins in vivo 
In vivo labeling was performed as described previously (Cao 2003). Bacteria 
were grown in LB medium with the required antibiotics until they reached stationary 
phase. The culture was used to inoculate complete MOPS medium. When the culture 
reached exponential phase, 2.5 x 109 cells were harvested by centrifugation and 
washed with 25 ml of 1x Tris buffered saline, pH 7.4 (TBS). The cells were 
resuspended in TBS at a cell density of 5 x 108 cells/ml. FM was prepared in N, N-
dimethylformamide (Sigma) and added to the cell suspension to a final concentration 
of 65 µM. The concentration of the stock fluorophore solution was determined by 
absorption spectrophotometry. The mixture was then incubated at room temperature 
protected from exposure to light. After 30 min, the mixture was centrifuged and the 
cell pellet was washed thrice in ice cold TBS. The cells were then resuspended in ice-
cold complete MOPS medium and stored on ice until further manipulation. 
Fluorescence spectrophotometry 
Fluorimetric measurements were performed as described previously. I used a 
SLM 8000 fluorospectrophotometer (Rochester, New York) upgraded to SLM 8100. 
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We recorded the fluorescence of 5 x 107 bacteria in 2 ml of complete MOPS medium. 
The temperature was equilibrated with a water bath. For FM labeled samples, I 
recorded the fluorescence intensity at excitation wavelength, 490 nm and the emission 
wavelength, 518 nm. Background fluorescence was monitored with bacteria 
expressing wild type FepA, incubated with the fluorophore. 
Labeling in the presence of FeEnt 
Labeling accessibility was tested using SDS-PAGE. Bacteria were grown as 
for FM labeling and washed with 1x TBS. However, only 3-5 x 108 cells were 
collected and labeling performed in 1.5 ml centrifuge tubes. After washing, the cells 
were resuspended at a density of 5 x 108 cells/ml and chilled on ice. FeEnt was added 
and allowed to equilibrate with the binding site. The cells were incubated on ice for 
10 to 15 min. Fluorophore was added and the mixture was either incubated on ice for 
30 min or transferred to 37°C. The cells were subsequently washed and processed for 
SDS-PAGE.
Detection of labeling 
For detection of FM or AM labeled proteins, I lysed the cells by suspending 
them in sample buffer. The cell lysates were boiled for 5 min and centrifuged to 
remove cell debris for 1 min. The supernatant was resolved by SDS-PAGE. The gel 
was directly scanned for fluorescent protein bands using the fluorescence detector of 
the STORM scanner (Molecular Dynamics). I used the blue fluorescence setting to 
identify FM and AM labeling. In my labeling experiments, I included mutant 
constructs of FepA such as FepAS271C that have been previously showed to be 
strongly labeled by the fluorophores (Cao 2003) as controls for the labeling reaction 
and detection on SDS-PAGE. I also transferred the protein bands to nitrocellulose 
membranes and scanned the latter, but this method reduced the sensitivity of 
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detection. Alternatively, I detected the FM labeled protein bands by western blotting 
polyclonal serum developed in rabbit immunized with a conjugate of bovine serum 
albumin (BSA) and Fluorescein iodoacetamide. The blots were developed either with 
125I-Protein A or colorimetrically with alkaline phosphatase substrates. For the latter, I 
used a dilute conjugate of anti-rabbit Ig immunoglobulin developed in goat and 
alkaline phosphatase.  In each experiment, I also monitored the expression of FepA by 




Aromatic residues in the binding and transport of FeEnt
All the experiments detailed in this section were performed in collaboration with my 
colleague, Bo Jin. 
Identification of candidate residues for mutagenesis 
The amino acid sequences of various FeEnt transporters of different Gram-
negative bacteria and E. coli LGPs were aligned (Cao 2000) by the PILEUP algorithm 
(Genetics Computer Group, Madison WI) and adjusted based on the crystal structure 
of FepA (Buchanan 1999) and FhuA (Locher 1998 and Ferguson 1998). The 
alignments were examined for the presence of conserved aromatic residues in the 
surface loops and the top of the N domain that could potentially participate in the 
binding interaction. Residues that were at least 70% conserved among the different 
receptors were selected for this study, namely tyrosines 472, 478, 481 and 495 (Figure 
6). Less conserved tyrosines 217, 488, 540, 553 and 638 in the surface loops and 
tryptophan 101 in the ‘sensor’ loop NL2 of the N domain (Buchanan 2000) were also 
included. 
Protein expression and localization 
The low copy plasmid pITS23 (Scott 2001) is present at a copy number of 2 to 
3/per bacterium. pITS23 is a derivative of pHSG575 expression vector (Hashimoto-
Gotoh 1981). Under the conditions of iron starvation used in our experiment, the fepA
gene in pITS23 translates into approximately 43,000 molecules of FepA per cell. The 
mutations were engineered on pITS23. The expression levels of all the constructs 
were determined by quantitative 125I-Protein A (Kronvall 1970, Newton 1997) 
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western blotting. All the protein constructs were expressed at levels similar to wild 
type FepA (Figure 6a). The localization of the protein in the OM was similar to wild 
type for all the mutants (Figure 7). The localization of the FepA derivatives was also 
verified by flow cytometric analysis (Annamalai & Jin 2004).
Colicin sensitivity
 The susceptibility to colicin killing (Cao 2000) is not only a measure of the 
protein’s localization, but is also an indicator of the protein’s proper assembly and 
functionality. The mutations caused different effects on the sensitivity to colicin B 
and colicin D. Mutations W101A and Y553A caused more than a 20-fold reduction in 
colicin sensitivity, while the other mutants had more modest (< 10-fold) reductions. 
Y472A causes a 90% reduction in susceptibility to colicin B but does not affect 
susceptibility to colicin D. This suggests that the residue is involved in the reaction 
with colicin B but not the latter. FepA Y217 A and Y488A also show similar, albeit 
more modest differences. However, other mutations have similar effects on the 
interaction with both the colicins. Taken together, the data implies that while the 
points of interaction between the colicins and FepA overlap as to the identity of the 
participating residues, there are also significant differences. The interaction between 
the macromolecules presumably involves large regions of each protein and it is not 
surprising that these regions encompass several individual amino acid determinants. 
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Figure 6. Target residues for alanine mutagenesis (Figure by Klebba in Annamalai and Jin 2004).
On the left is the space-filled representation of FepA (Buchanan 1999) looking from the cell exterior 
into the barrel. On the right, the protein backbone is viewed in the plane of the membrane bilayer. 
Tyrosines 217, 472, 478, 481, 495, 540, 553 and 638 are depicted in yellow. Tyrosine 488 was not 
identified in the crystal structure and the oval symbol indicates its expected position. Residues that 
were investigated in previous studies are also included. Trytophan 101 at the top of NL2 was also 
included in this study. The putative two binding sites, B1 and B2 are marked with red ellipses. It can be 
seen that B1 contains a zone of aromaticity and lysine 483. B2 has both aromatic and basic including 
tyrosine 260 and arginine 316 respectively. Also included is the crystal structure of vanadium 
enterobactin (labeled FeEnt, see text). 
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Figure 6a. Expression of FepA and its derivatives. Whole cell lysates of E. coli KDF541 harboring 
plasmid pHSG575 expressing wild type FepA (pITS23) or its derivatives were resolved by SDS-PAGE 
and immunoblotted with Mouse anti-FepA monoclonal antibody, mab45 and 125I-Protein A. The bands 
were revealed by phosphor imaging (Molecular Dynamics). Lane order from for lanes 1 to 12 is 
KDF541 expressing no FepA, wild type FepA, FepA W101A, Y217A, Y472A, Y478A, Y481A, 
Y488A, Y495A, Y540A, Y553A and Y638A respectively. 
FepA
52
Figure 7. Localization of FepA and its derivatives. OMs of E. coli KDF541 harboring plasmid 
pHSG575 expressing wild type FepA (pITS23) or its derivatives were resolved by SDS-PAGE. The 
bands were revealed by staining with coomassie blue. Lane order from for lanes 1 to 12 is KDF541 
expressing no FepA, wild type FepA, FepA W101A, Y217A, Y472A, Y478A, Y481A, Y488A, 
Y495A, Y540A, Y553A and Y638A respectively. 
Figure 8. Sensitivity to colicins B and D. KDF541 expressing FepA or its derivatives from pHSG575 
was plated on solid media and exposed to serial dilutions of colicins B (shaded bars) and D (open bars). 
The susceptibility to colicin killing was expressed in arbitrary titration units, defined as the reciprocal 
of the highest dilution of colicin that caused a clearing of the bacterial lawn. The data was plotted as the 





Figure 9. Siderophore nutrition assay of FepA and its derivatives. Bacterial cultures in their 
logarithmic phase are plated in iron deficient media containing the iron chelator, apoferrichrome A and 
a paper disc is placed in the center of the agar. 50 pmol of FeEnt is pipetted onto the center of the disc. 
The plates are incubated overnight. The zone of bacterial growth (halo) is photographed with an 
Olympus® digital camera. The grid is introduced electronically using Adobe Photoshop® software. E. 
coli KDF541with no plasmid (top left) or hosting pITS23 (expressing wild type FepA) were tested to 
provide and positive controls respectively. The aminoacid substitution in the FepA protein is listed 
under each photograph. 
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Aromatic residues in the binding interaction: 
The in vivo binding capabilities (Newton 1999, Cao 2000) of the aromatic 
substitution mutants were compared to that of the wild type (Table 5). The difference 
in their Kds enabled their classification into different classes. FepA Y217A, Y488A 
and Y553A showed wild-type binding capabilities. These residues probably play little 
role in binding. FepAW101A, Y472A, Y478A, Y495A and Y540A demonstrated 3 to 
5-fold defects in binding. The order of importance among these residues is Y472 > 
Y540 > W101> Y495 > Y478. FepAY481A and Y638A showed more than a 10-fold 
reduction in binding affinity. Y481A is a significant component of the binding 
interaction. Its substitution produced the largest defect identified in this study. 
The capacities of the mutants, W101A and Y638A were very low, compared 
to wild-type. The capacity of binding represents the maximum number of available 
binding sites on FepA proteins expressed on the cell surface. However, these proteins 
were expressed and localized similar to wild-type FepA. The difference in the 
capacity therefore does not derive from different numbers of the mature proteins on 
the protein surface. The replacement of these residues directly affects the formation of 
the protein’s binding site.  In the absence of these aromatic residues a large proportion 
of the receptors do not assume an optimal conformation for binding. 
Aromatic residues in the transport of FeEnt 
The siderophore nutrition test measures the overall uptake, both binding and 
transport, capabilities of the protein. All the mutants tested showed a difference in 
their phenotype, when compared to wild type FepA (Figure 9). Although the assay 
serves only as a screening test, the diameter and the appearance of the zone of growth 
(halo) have some correlation to the functionality of the mutant protein (Table 5). The 
wild type consistently gives a dense zone of growth with sharp borders. Generally, 
55
mutants with the greatest deficiency in transport capabilities gave much fainter and 
larger (> 2 mm difference) zones of growth, compared to wild type. FepAW101A, 
Y478A, Y481A, Y495A and Y638A follow this pattern. On the other hand, mutants 
that showed sharp or fuzzy halos and halos close in size (difference< 2mm) to wild 
type had moderate deficiencies in their transport capabilities (see below). 
FepAY217A, Y488A and Y553A are members of this second set. Eor example, 
FepAY540A, which produces a faint halo with the largest diameter among the 
mutants reported here showed only a moderate reduction in its transport capabilities. 
In radioisotopic transport studies, all the mutants studied showed defects in 
their transport capabilities albeit to different degrees (table 5). The transport defects of 
Y472A, Y481A, Y488A, and Y540A were commensurate with their binding 
deficiencies. Among these, Y481A produced the biggest defect. Its Km was 18 fold 
higher than the wild type. Such mutations were named class I mutations (Figure 10a, 
10b and 10c). The major contribution of these residues was to the binding reaction 
and the effect of their substitution on transport derived from that on binding. 
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Figure 10a. Binding and transport by class I substitution mutants. Wild type FepA (circles) and 
FepAY481A (squares) were expressed from pHSG575 in E.coli KDF541. The concentration 
dependence of binding (open symbols) and transport (closed symbols) was determined at six 
concentrations of 59FeEnt. The data was analyzed and plotted by using the bound-versus-total and 
enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
Figure 10b. Binding and transport by class I substitution mutants. Wild type FepA (circles), 
FepAY472A (diamonds) and Y540A (triangles) were expressed from pHSG575 in E.coli KDF541. The 
concentration dependence of binding (open symbols) and transport (closed symbols) was determined at 
six concentrations of 59FeEnt. The data was analyzed and plotted by using the bound-versus-total and 
enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
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Figure 10c. Binding and transport by class I substitution mutants. Wild type FepA (circles) and 
FepAY488A (stars) were expressed from pHSG575 in E.coli KDF541. The concentration dependence 
of binding (open symbols) and transport (closed symbols) was determined at six concentrations of 
59FeEnt. The data was analyzed and plotted by using the bound-versus-total and enzyme kinetics 
equation of Grafit 5.0.9 (Erithracus).
Figure 11a. Binding and transport by class II substitution mutants. Wild type FepA (circles), 
FepAY478A (inverted triangles) and FepAY638A (stars) were expressed from pHSG575 in E.coli
KDF541. The concentration dependence of binding (open symbols) and transport (closed symbols) was 
determined at six concentrations of 59FeEnt. The data was analyzed and plotted by using the bound-
versus-total and enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
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The defects in transport did not always mirror the defects in binding. Y478A 
and W101A severely affected the transport but not binding. This is evident from their 
very high Km of transport. The Km of W101A is apparently so high that it could not be 
accurately determined in our experiments. We were unable to measure the maximal 
velocity of transport at saturating levels of substrate concentration. Y217A, Y553A 
and Y638A produced smaller increments in the Km. This group of mutations were 
classified as class II mutations (Figure 11a, 11b and 11c). The primary contribution of 
these residues appears to be to the transport process and their substitutions produced 
disproportionate effects on transport when compared to binding. Y638A produced a 
10 fold increase in binding Kd, but resulted in a 77-fold increase in the transport Km. 
The residue appears to contribute both to the binding and transport reaction, but has a 
larger role in the latter process. Its substitution therefore is a class II substitution. 
Y495A is the sole example of a class III mutation, with a near wild type Kd, 
Km and capacity, but a 5-fold lower Vmax and therefore a low turnover number, k8. 
This class of mutation affected the efficiency of the transport process (Figure 12a). 
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Figure 11b. Binding and transport by class II substitution mutants. Wild type FepA (circles) and 
FepAW101A (hexagons) were expressed from pHSG575 in E.coli KDF541. The concentration 
dependence of binding (open symbols) and transport (closed symbols) was determined at six 
concentrations of 59FeEnt. The data was analyzed and plotted by using the bound-versus-total and 
enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
Figure 11c. Binding and transport by class II substitution mutants. Wild type FepA (circles), 
FepAY217A (squares) and FepAY553A (triangles) were expressed from pHSG575 in E.coli KDF541. 
The concentration dependence of binding (open symbols) and transport (closed symbols) was 
determined at six concentrations of 59FeEnt. The data was analyzed and plotted by using the bound-
versus-total and enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
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Figure 12. Binding and transport by class III substitution mutant. Wild type FepA (circles) and 
FepAY495A (diamonds) was expressed from pHSG575 in E.coli KDF541. The concentration 
dependence of binding (open symbols) and transport (closed symbols) was determined at six 
concentrations of 59FeEnt. The data were analyzed and plotted by using the bound-versus-total and 
enzyme kinetics equation of Grafit 5.0.9 (Erithracus).
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FeEnt
FepA Loop Bindinga Transportb Flow cytometryd
Kd Capacity Nutrition Km Vmax k8
c mab24 mab45
Wild type NA 0.27 67 18.5 0.4 113 1.7 4.2 45.2 
Class I
Y472A 7 1.5 68 19 2.6 105 1.5 8.34 42.4 
Y481A 7 4.8 47 21 7.2 44 0.9 11.3 42.6 
Y488A 7 0.5 38 19.5 0.6 156 4.1 3.5 38.5 
Y540A 8 1.4 56 23 2.0 98 1.8 10.1 45.9 
Class II
W101A NL2 0.85 12 20.5 393* 269* NC 8.8 54.6 
Y217A 2 0.20 58 18.5 1.3 122 2.1 3.5 44.1 
Y478A 7 0.76 49 21 167 184 3.8 14.2 34.8 
Y553A 8 0.40 46 20.5 2.1 100 2.2 7.2 47.3 
Y638A 10 2.9 3 22 31 93 31 4.1 38.5 
Class III
Y495A 7 0.79 44 21.5 0.9 17 0.4 8.8 39.1 
Table 5. Binding and transport by FepA and its derivatives. The proteins were expressed from 
pHSG575 in E. coli KDF541. Class I, comparable increases in binding Kd and transport Km; class II, 
larger increase in transport Km; class III, reduction in transport rate.  
a. Binding. Kd (nM) and capacity (pmol bound/109 cells) were determined from the concentration 
dependence of FeEnt binding by analyzing the mean values from independent experiments with 
GRAFIT 5.0.9 (Erithacus), using the `bound versus total' equation. 
b. Transport. Nutrition – the diameter of the zone of bacterial growth is listed in mm (see text for 
details). Km (nM) and Vmax (pmol transported/10
9 cells/min) of uptake were determined from the 
concentration dependence of FeEnt transport using GRAFIT 5.0.9 (Erithacus), using the `enzyme 
kinetics' equation. 
c – k8 corresponds to the turnover number of the transporter, a value akin to k3, the catalytic turnover 
number of enzymes (Scott 2001). k8 = Vmax/Capacity, molecules/receptor protein/min. 
* - We were not able to measure transport rate at saturating concentrations of FeEnt for W101A. Km
and Vmax values were estimated from trends observed with unsaturated transport rate measurements. 
NC – Not calculated as Vmax could not be determined. 
d. Data was collected on Elite Coulter cell sorter by Salete Newton. Samples were prepared by 
incubating bacteria with Mouse anti-FepA antibodies, mab 24 and mab 45, which recognize epitopes 
on loops L4 and L5 of FepA respectively.  The values listed are mean fluorescence intensity of 104
bacteria and in parenthesis is the percentage of the bacterial population that gives signals within one 
standard deviation of the mean (Annamalai and Jin 2004). 
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Chapter 4
Loops of the N-domain
The experiments in this section were performed in collaboration with my colleague, 
Bo Jin. 
Site directed mutagenesis 
The loops of the N domain, NL1 and NL2 (Figure 13) extend from residues 54 
to 75 and 91 to 115 of the FepA polypeptide respectively (Buchanan 1999). Carla 
Taddei, Melissa Simoes, Simone Alves, and Tie Koide constructed fepA∆60-67 in 
which the central segment of NL1 is deleted. Similarly, Alexandre Moutran, Marcio 
Lasaro and Solange Nunes constructed fepA∆98-105, which carries the deletion in 
NL2. The mutations were engineered on pITS449 (pUC18fepA+). E. coli KDF541 
served as the host bacterium for the resultant plasmid constructs. The work was 
carried out under the tutelage of Dr. Klebba, Dr. Newton and Dr. Scott under the 
auspices of the American Society for Microbiology-sponsored International Training 
Program for Latin America: “Molecular Biological Approaches to Bacterial Cell Wall 
Biochemistry,” in April 2002 at Departamento de Microbiologia, Universidade de Sao 
Paulo, Sao Paulo, Brazil. 
Protein expression and localization
The expression levels of all the constructs were determined by quantitative I-
125I-Protein A western blotting. All the protein constructs were found to be expressed 
and localized to the OM at levels similar to wild type FepA (Figure 14, Figure 15). 
The localization of the mutated proteins was also verified by flow cytometric analysis 
(Annamalai & Jin 2004).
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Figure 13. Loops of the N domain of FepA. The segments deleted in the superior portion of NL1 
(red) and NL2 (orange) are depicted in the protein backbone of FepA (Buchanan 1999). The view is 
from the cell exterior looking into the barrel. The backbone is depicted in grayscale. Tryptophan 101 is 
represented in spacefilled form to identify NL2. The loops are well situated to interact with the ligand 
(Figure by Klebba in Annamalai and Jin 2004). 
1      2       3
Figure 14. Expression of FepA and its derivatives. Whole cell lysates of E. coli KDF541 harboring 
plasmid pUC18 expressing wild type FepA (pITS449) or its derivatives were resolved by SDS-PAGE 
and immunoblotted with Mouse anti-FepA monoclonal antibody, mab 45 and 125I-Protein A. The bands 
were revealed by phosphor imaging (Molecular Dynamics). Lane order from for lanes 1 to 3 is 
KDF541 expressing wild type FepA, FepA 60-67 and FepA 98- 105 respectively (Annamalai and Jin 
2004).
                                                                 1       2      3 
Figure 15. Localization of FepA and its derivatives. OMs of E. coli KDF541 harboring plasmid 
pUC18 expressing wild type FepA (pITS449) or its derivatives were resolved by SDS-PAGE. The 
bands were revealed by staining with coomassie blue. Lane order from for lanes 1 to 3 is KDF541 
expressing wild type FepA, FepA 60-67 and FepA 98-105 respectively (Annamalai and Jin, 2004). 
FepA
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Figure 16. Sensitivity to colicins B and D of N domain loop deletion mutants. KDF541 expressing 
wild type FepA or its derivatives from pUC18 was plated on solid media and exposed to serial dilutions 
of colicins B and D. The susceptibility to colicin killing was expressed in arbitrary titration units, 
defined as the reciprocal of the highest dilution of colicin that caused a clearing of the bacterial lawn. 
The data was plotted as the ratio of mutant titer to wild type titer in percentage units.  
      pITS449     FepA 60-67 FepA 98-105
Figure 17. Siderophore nutrition assay of FepA and its derivatives. Bacterial cultures in their 
logarithmic phase were plated in iron deficient media containing the iron chelator, apoferrichrome A 
and a paper disc was placed in the center of the agar. 10 µl of 50 µM FeEnt was pipetted onto the 
center of the disc. The plates were incubated overnight. The zone of bacterial growth (halo) was 




Both the deletion mutations conferred sensitivity to killing by both colicin B 
and D upon bacteria expressing the protein constructs. When compared to wild type 
FepA, the mutant constructs exhibited 10-fold reduced activity (Figure 16). 
Binding and transport by N domain loop deletion mutants 
The binding and transport of the N domain loop deletion mutants were 
compared to wild type FepA expressed from pITS449. The plasmids were hosted by 
E. coli KDF541. The deletion mutations gave rise to class II defects in FepA function 
(Table 6). Siderophore nutrition tests demonstrated larger zones of growth with 
diffuse borders for the deletion mutants when compared to wild type (Figure 17). 
When compared to wild type FepA, the Kd of binding was increased 18- and 28- fold 
by the 60-67 and 98-105 deletions (Table 6). However, transport was impaired 
500- and 700-fold as evident from the increase in their Km of transport. These 
parameters resemble the defects identified with Y638A, although the loop deletions 
affected transport more severely. 
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Figure18. Binding and transport by N-loop deletion mutants. (Open symbols) 59FeEnt binding and 
59FeEnt uptake (solid symbols) by E. coli KDF541 harboring pUC18 plasmids, expressing fepA+
(circles, pITS449), fepA 60-67 (squares), and fepA 98-105 (triangles) alleles. The binding and 
transport data were analyzed and curves were plotted by using the bound-versus-total and enzyme 
kinetics equations, respectively, of Grafit 5.09 (Annamalai and Jin 2004).
FeEnt
FepA Loop Bindinga Transportb Flow cytometryd
Kd Capacity Nutrition Km Vmax k8
c mab 24 mab 45
fepA+ NA 0.41 150 18 0.24 123 0.8 4.1 (80) 11.7 (90)
Class II
60-67 NL1 7.3 119 25 99 119 0.8 6.2 (91) 11.5 (93)
98-105 NL2 11.7 107 25 88 163 0.8 6.57 (91) 12.6 (88)
Table 6. Binding and transport by FepA N domain loop deletion. The proteins were expressed from 
pUC18 in E. coli KDF541. Class II, mutation causing larger increase in transport Km. 
a. Binding. Kd (nM) and capacity (pmol bound/109 cells) were determined from the concentration 
dependence of FeEnt binding by analyzing the mean values from independent experiments with 
GRAFIT 5.0.9 (Erithacus), using the `bound versus total' equation. 
b. Transport. Nutrition – the diameter of the zone of bacterial growth is listed in mm (see text for 
details). Km (nM) and Vmax (pmol transported/10
9 cells/min) of uptake were determined from the 
concentration dependence of FeEnt transport using GRAFIT 5.0.9 (Erithacus), using the `enzyme 
kinetics' equation. 
c – k8 corresponds to the turnover number of the transporter, a value akin to k3, the catalytic turnover 
number of enzymes (Scott 2001). It relates the Vmax of transport to the capacity of binding, k8 = 
Vmax/Capacity, molecules/receptor protein/min. 
d. The data was collected on Elite Coulter cell sorter by Salete Newton. Samples were prepared by 
incubating bacteria with mouse anti-FepA antibodies, mab24 and mab45, which recognize epitopes on 
loops L4 and L5 of FepA respectively.  The values listed are mean fluorescence intensity of 104
bacteria and in parenthesis is the percentage of the bacterial population that gives signals within one 
standard deviation of the mean (Annamalai & Jin 2004). 
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Chapter 5
Recognition of ferric catecholates by FepA
The experiments in this section were performed in collaboration with my 
colleague, Bo Jin. 
Binding of ferric catecholates
We tested the ability of bacteria expressing FepA to bind the ferric 
catecholates FeEnt, FeTRENCAM and FeCorynebactin (Figure 19). Among these, 
FeCorynebactin showed no adsorption to FepA even at a concentration of 1 µM. 
FeTRENCAM bound with a Kd of 17 nM, which is about 50 times greater than the Kd
of the FepA-FeEnt adsorption. The results are different from previous reports 
(Thulasiraman 1998), which placed the Kd for binding FeTRENCAM (27 nM) at 
nearly twice the FeEnt Kd (17 nM). However, subsequent reports (Newton 1999) 
identified substrate depletion as a distorting factor in the original report. At low 
concentrations of substrate, the concentration of the unbound ligand decreases as the 
binding reaction proceeds. At low volumes of the reaction, this leads to a significant 
decrease in the amount and thereby the concentration of the ligand. By performing the 
reaction at large volumes, the authors avoided this large depletion in the ligand 
concentration. The current experiments were performed with the newer protocols. 
Transport of ferric catecholates
Among the three ferric catecholates tested (Figure 19), only the native 
siderophore and FeTRENCAM are transported. The Km of transport for 
FeTRENCAM was 4.5 nM, which is 18 times that for FeEnt. Similar to binding, these 
experiments were performed with the newer protocol to avoid depletion effects. 
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Competition of FeEnt with other siderophores 
We compared the ability of different ferric siderophores to inhibit the binding 
of 59FeEnt (Figure 20). Among the panel that we studied, we included the catecholates 
FeEnt (for the identity reaction), FeTRENCAM, FeCorynebactin, FeAgrobactin and 
the hydroxamate Fc. Only the first three catecholates showed inhibition of 59FeEnt 
binding. We calculated the IC50 (inhibitory concentration) of the binding, using the 4-
parameter fit of Grafit 5.0, Erithracus. FeEnt reduced the adsorption of 59FeEnt to 
50% of the uninhibited value at a concentration of 0.67 nM (inhibitory concentration 
50, IC50). This value is close to its Kd (0.27 nM). The IC50 of FeTRENCAM was 
around 120 nM, reflecting its lower affinity for the receptor. Even at a concentration 
of 25 µM, FeCorynebactin only showed 50% inhibition of 59FeEnt adsorption. This 
concentration is nearly 100,000 times the Kd of FeEnt binding. Despite its catecholate 
structure, FeAgrobactin did not inhibit 59FeEnt binding. The hydroxamate Fc showed 
no effect either. Neither of these two siderophores supply iron to bacteria through 
FepA (Thulasiraman 1998, Scott 2001). 
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Figure 19. Binding and transport of ferric catecholates. We compared the binding (open symbols) 
and transport (solid symbols) of 59FeEnt (inverted triangles), 59FeTRENCAM (triangles), and 
59FeCorynebactin (diamonds) by E. coli strain KDF541/pITS23 (Annamalai & Jin 2004). 
Figure 20. Competition of 59FeEnt binding to FepA by ferric siderophores. We determined the 
abilities of Fc (□), FeAgrobactin ( ), FeTRENCAM ( ), FeCorynebactin ( ), and FeEnt ( ) to inhibit 
the binding of 59FeEnt to E. coli strain KDF541/pITS23 (fepA+). The data were analyzed and plotted by 
the IC50-4 Parameter Logistic of Grafit 5.09 (Annamalai & Jin 2004). 
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Chapter 6
Complementation between isolated barrel and N domains
Expression of FepA and FhuA protein constructs
E. coli strains carrying precise deletions of the structural genes (see 
immediately below) of FepA (OKN3) and FhuA (MB97) alone or in combination 
(OKN73) were transformed with plasmids expressing the N domain deletion mutants 
of FepA (Fepβ) and FhuA (Fhuβ) (Scott 2001). Similarly the chimeric FhuNFepβ and 
FepNFhuβ protein constructs were expressed in these strains. Further, I retransformed 
E. coli KDF 541 with the same plasmids. I then proceeded to compare the 
functionality of the different protein constructs when expressed in the different 
strains.
OKN3 was constructed by Salete Newton following the Datsenko-Wanner 
method. The strain was constructed by deleting the FepA gene from BN1071 (Klebba 
1992). E. coli MB97 (AB2847 fhuA), constructed using the same methodology was a 
gift from Volkmar Braun (Braun 2003). We also constructed a fepA- derivative of 
MB97, which we dubbed OKN73. OKN73 is similar to MB99 (Braun 2003). 
Colicin susceptibility 
FepA derivatives and colicins B and D. I measured the susceptibility of Fepβ
and the chimeric FhuNFepβ to colicins B and D (Table 7). Both these constructs did 
not confer any colicin B or D sensitivity to strains carrying complete deletions of the 
fepA and fhuA genes (OKN73). The presence of genome-encoded FhuA (in OKN3) 
did not rescue the constructs either. However, the concurrent presence of either 
genomically encoded FepA1-363 fragment (in KDF541) or plasmid encoded FepN 
restored Fepβ’s sensitivity to both colicin B and D. FepA1-363 also complemented 
FhuNFepβ. The complementation did not restore the sensitivity to wild type levels. 
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FhuA derivatives and colicin M. I measured the susceptibility of strains 
expressing Fhuβ and FepNFhuβ to purified colicin M (Table 8). In OKN73 (fepA-
fhuA-) and MB97 (fhuA-), both these constructs had no activity. Coexpression of 
plasmid encoded FepN (FepA1-150) did not restore Fhuβ’s activity. Nor did OM 
localized FepA-PhoA fusions with increasing lengths (100, 227, 258, 290 and 352 
amino acids) of FepA N terminal segments complement Fhuβ. However, Fhuβ was 
active in KDF541 (see below). 








B D B D B D
-/- - - - - - - 
wt. FepA 100 100 100 100 100 100
Fepβ - - - - 6.25 1
FhuNFepβ - - - - 0.75 0.1
FepN - - - - - -
Fepβ + FepN 0.45 0.006 3.25 0.15 6.25 1.5
Table 7. Colicin B and D sensitivity of FepA derivatives. The different protein constructs were 
encoded on the low copy plasmid vector, pHSG575. pHSG575 carries the Chloramphenicol 
acetyltransferase (cat) gene and confers resistance to the antibiotic chloramphenicol. The isolated N 
domain of FepA was expressed from high copy pUC18 vector, which confers ampicillin resistance. 
Bacteria were grown overnight in LB medium with appropriate antibiotics. The culture was plated on 
LB plates and serial dilutions of purified colicin B and D were applied (see materials and methods) 
using the clonemaster (Immusine). The plates were then incubated over night at 37°C. The plates were 
then examined for clearance of the bacterial lawn. The sensitivity to colicin was recorded in arbitrary 
dilution units or titers defined as the maximum dilution that cleared the bacterial lawn. In the table, the 
titers are listed as percent wild type titers (derivative titer/wild type FepA titer x 100%) to compare 
between experiments. * - the fhuA locus of KDF541 has not been fully described (see text).
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-/- - - - 
Wild type 100 100 100
Fhuβ - - 50
FepNFhuβ - - -
Fhuβ + FepN - ND ND
Fhuβ + FepA1-100::PhoA - ND ND
Fhuβ + FepA1-227::PhoA - ND ND
Fhuβ + FepA1-258::PhoA - ND ND
Fhuβ + FepA1-290::PhoA - ND ND
Fhuβ + FepA1-352::PhoA - ND ND 
Table 8. Colicin M sensitivity of FhuA derivatives. The different protein constructs were encoded on 
the low copy plasmid vector, pHSG575. The isolated N domain of FepA was expressed from high copy 
pUC18 vector, which confers ampicillin resistance. The different FepA-PhoA fusions were previously 
described (Murphy 1989). The proteins were encoded on high copy plasmid vector, pUC18. The 
resultant plasmids were named pFPxxx, where xxx indicates the number of residues of FepA retained 
in the fusion protein. Bacteria were grown overnight in LB medium with appropriate antibiotics. The 
culture was plated on LB plates and serial dilutions of purified colicin M were applied (see materials 
and methods) using the clonemaster (Immusine). The plates were then incubated over night at 37°C. 
The plates were then examined for clearance of the bacterial lawn. The sensitivity to colicin was 
recorded in arbitrary dilution units or titers defined as the maximum dilution that cleared the bacterial 
lawn. In the table, the titers are listed as percent wild type titers (derivative titer/wild type FhuA titer x 
100%) to compare between experiments. – No sensitivity. ND – Not performed. * - the fhuA locus of 
KDF541 has not been fully described (see text). 
73
Siderophore nutrition analysis 
I tested the ability of the different protein constructs to transport FeEnt (for 
FepA derivatives, Table 7) and Fc (for FhuA derivatives, Table 10). I found that the 
proteins Fepβ and the chimeric FhuNFepβ failed to transport FeEnt in bacteria with 
complete FepA deletions with (OKN73) or without (OKN3) complete FhuA 
deletions. However, the concurrent presence of genomically encoded FepA 1-363
fragment (in KDF51) restored Fepβ’s activity. FepA 1-363 also complemented 
FhuNFepβ. The coexpression of FepN did not restore the uptake. 
Fhuβ and the chimeric FepNFhuβ are inactive in the complete FhuA delection 
background with or without the complete FepA deletion. Plasmid encoded FepN 
(FepA (1-150)) did not restore Fhuβ’s activity. Nor did OM localized FepA-PhoA 
fusions with increasing lengths (100, 227, 258, 290 and 352 amino acids) of FepA N 
terminal segments complement Fhuβ. However, Fhuβ and the chimeric FepNFhuβ
were active in KDF541 (see below).
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-/- - -  
Wild type 16 17 17
Fepβ - - 21
FhuNFepβ - - 21
FepN - - -
Fepβ + FepN - - -
Table 9. FeEnt nutrition of FepA derivatives. – No growth observed. A sample of actively growing 
bacteria was plated with soft agar and an iron chelator, apoferrichrome A. A paper disk was then placed 
on top of the solidified agar and 500 pmoles of pure FeEnt was added to the center of the disc. The 
plates were incubated at 37°C for 6 to 8 hours. The diameter of the zone of bacterial growth around the 
disc was recorded in mm. * - the fhuA locus of KDF541 has not been fully described. 







-/- - - - 
Wild type 15 18 16
Fhuβ - - 16
FepNFhuβ - - 22
Fhuβ + FepN - ND ND
Fhuβ + FepA1-100::PhoA - ND ND
Fhuβ + FepA1-227::PhoA - ND ND
Fhuβ + FepA1-258::PhoA - ND ND
Fhuβ + FepA1-290::PhoA - ND ND
Fhuβ + FepA1-352::PhoA - ND ND
Table 10. Fc nutrition of FhuA derivatives. – No growth observed. ND – No data. A sample of 
actively growing bacteria were plated with soft agar and an iron chelator, apoferrichrome A. A paper 
disk was then placed on top of the solidified agar and 500 pmoles of pure Fc was added to the center of 
the disc. The plates were incubated at 37°C for 6 to 8 hours. The diameter of the zone of bacterial 
growth around the disc was recorded in mm. * - the fhuA locus of KDF541 has not been fully 
described (see text). 
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Figure 21. 125I-Protein A immunoblot profiling the expression of FepA derivatives. Bacteria were 
grown in iron deficient MOPS medium and harvested by centrifugation. The cell pellets were lysed and 
resolved by SDS-PAGE. The protein bands were electroeluted onto nitrocellulose membranes and a 
radioimmunoblot was performed. Mab45, a monoclonal antibody that recognizes an epitope on the C 
domain was used as the primary antibody. In lanes 1-5 are whole cell lysates from KDF541. In lanes 6-
10 are samples from OKN3 and in lanes 11-15 are samples from OKN73. For the group from each 
strain, lane order from left to right are bacteria hosting no plasmid, plasmid expressing wt FepA 





FepA and FhuA derivatives. To investigate whether the differences in the 
phenotypes observed derived from differences in the expression of the protein 
constructs, I performed immunoblots on whole cell lysates of bacteria expressing 
these proteins. I used ascites fluids containing monoclonal antibodies directed against 
epitopes in the C domain of FepA (between amino acids 290-339, Mab 45, Figure 21) 
and the N domain of FepA (Mab41, Figure 22) to observe expression of the FepA 
protein constructs from the different strains. For FhuA derivatives, the expression of 
FepNFhuβ is profiled in figure 22a. MB97 expresses native FepA from its genome. 
Mab41 will therefore recognize the protein in addition to FepNFhuβ. We did not have 
access to an antibody that recognizes FhuA C domain. We did not therefore have a 
direct method to observe Fhuβ bands. On the other hand, the construct confers 
sensitivity to colicin M at a different level from wild type FhuA in KDF541, 
indicating the localization to OM. FhuA and Fhuβ have also been reported to localize 
to the OM when expressed in MB97 and MB99 (similar to OKN73) (Braun 2003). 
We also observed expression of FhuA derivatives in KDF541 and MB97 as part of the 
TEV protease experiments (Figures 23 and 28).
77
FepNFhuβ
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Figure 22. Western blot profiling the expression of FepA derivatives. Bacteria were grown in iron 
deficient MOPS medium and harvested by centrifugation. The cell pellets were lysed and resolved by 
SDS-PAGE. The protein bands were electroeluted onto nitrocellulose membranes and a 
radioimmunoblot was performed. The blot was performed using mab41, a mouse anti-FepA Ig which 
recognizes an epitope in the N domain. In lanes 1-4 are whole cell lysates from KDF541. In lanes 5-8 
are samples from OKN3 and in lanes 9-12 are those from OKN73. For the group from each strain, lane 
order from left to right are bacteria hosting no plasmid, plasmid wt FepA (pITS23), plasmid 
FepN+Fepβ and plasmid FepN. 
1      2     3
Figure 22a. Expression of FepNFhuβ. Whole cell lysates of E. coli KDF541 (lane 1), MB97 (lane 2) 
and OKN73 (lane 3) expressing FepNFhuβ from pHSG575 (Scott 2001) were resolved by SDS-PAGE 
and western blotted with Mouse anti-FepA N domainantibody, Mab 41. MB97 also expresses native 





Disposition of the N domain during transport
Protease accessibility of the N domain 
Introduction of TEV protease into the periplasm 
Bacteria expressing wild type FhuA and FhuATEV site 113-119 were grown 
overnight in LB medium with the appropriate antibiotics. The culture was used to 
inoculate complete MOPS medium at a dilution of 1 in 100. After growth to 
stationary phase, the bacteria were permeablized using the Calcium-Phosphate buffer 
with or without 5 units of TEV protease (See materials and methods). Calcium-
Phosphate permeablization delivers proteins into the periplasm of E. coli. After the 
permeablization, the bacteria were washed twice with isotonic saline. The cells were 
resuspended in complete MOPS medium. The permeablized cells were either 
subjected to transport assays (see below) or lysed by boiling in sample buffer. 
For detection of protease in cells, nitrocellulose membranes containing the 
SDS-PAGE resolved whole cell-lysates were subjected to western blotting. I used 
antibodies directed against TEV protease to detect the protein. Rabbit serum 
containing anti-TEV protease antibodies was a gift from Michael Ehrmann. Antibody 
X1E2 recognizes an epitope in the N domain of FhuA. The epitope is located on loop 
NL2 (amino acid residues 98-101) of FhuA (Crystal Archer, Rob Keely and Sarah 
Weiss). To recognize the above primary antibodies, I used anti-mouse Ig or anti-
Rabbit Ig developed in goat (Sigma). The secondary antibodies are conjugated to 
alkaline phosphate. I developed the blots colorimetrically. In figure 23, lanes 3 and 4 
show the presence of extraneous TEV protease in the bacterial cells. The absence of 
the band in lanes 1 and 2 demonstrates that it did not arise because of the 
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permeablization procedure. That the band did not arise due to spontaneous 
degradation of FhuATEV site 113-119 is indicated by its absence in lane 5. 
Although the exact mechanism of this process is not clear, it is believed to 
involve fusion of membranes promoted by the calcium and phosphate ions (Brass 
1986). The hyperosmolar buffer may also shrink the cytoplasm of the cell widening 
the periplasmic space (Neu 1965). The net result is the creation of large, transient 
pores in the OM. This allows protein molecules as large as 50 kDa to enter the 
periplasm (Brass, Methods in enzymology) by simple diffusion. The molecular weight 
of TEV protease (Invitrogen) is ~30, 000. The protease equilibrates between the 
extracellular fluid and the periplasm. The permeablization requires ice-cold 
temperatures. The low temperature presumably delays the closure of these pores. 
Upon transferring the suspension to room temperature, the pores reseal rapidly 
trapping the protease in the periplasm. After the permeablization, the bacteria were 
washed twice with isotonic saline. These washes remove only the protease loosely 
adherent to the surface of E. coli. The periplasmic protease is not removed. 
Proteolysis of control substrate by introduced TEV protease: 
In order to demonstrate that the TEV protease is active in the periplasm of the 
bacteria, I tested the proteolysis of control substrate, MBP-TEVsite-PhoA. MBP-
TEVsite-PhoA is a soluble fusion of E. coli maltose binding protein (MBP), a linker 
containing the TEV recognition amino acid sequence, ENLYFQG (TEV site) and E. 
coli alkaline phosphatase (PhoA). The fusion protein was encoded from plasmid 
pMER1, a gift from Dr. Micheal Ehrmann. The fusion protein was expressed in E. 
coli CC118 (F- ∆(ara-leu)7697 araD 139 ∆lacX74 galE galK ∆phoA20 thi rpsE rpoB 
argE (Am) recA1 appR1) (Manoil 1985). Bacteria were permeablized and 50 units of 
TEV protease was introduced into the periplasm. The introduced enzyme cleaved the 
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fusion protein, liberating PhoA from the fusion protein. This is evidenced by the 
appearance of a band of the PhoA protein in the western blot (Figure 24). 
The gene for MBP-TEV site-PhoA fusion also encodes the signal sequence for 
malE. Therefore, it is expressed in the periplasm of bacteria. Since the host strain 
CC118 lacks the phoA gene, the appearance of PhoA serves as an indicator for 
proteolysis. This reaction can be either mediated by the introduced TEV protease or 
unknown proteases or spontaneously. The latter two scenarios are excluded by the 
absence of detectable proteolysis in the absence of introduced TEV protease. The 
introduced TEV protease cleaves the target. This reaction could occur in the 
periplasm or the cytoplasm. In this regard, the permeablization procedure that I 
employed delivers the enzyme primarily into the periplasm and not into the cytoplasm 
(Brass, methods in enzymology). Therefore, the proteolysis probably happens in the 
periplasm and not in the cytoplasm.
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Figure 23. Western blot showing the retention of TEV protease by permeablized cells.  I used a 
mixture of diluted X1E2 (Mouse anti-FhuA Ig) and Rabbit anti-TEV protease Ig as primary antibodies. 
The secondary antibodies were alkaline phosphatase conjugates. The blots were developed 
colorimetrically using substrates NBT and BCIP. Lanes 1-5 contains samples from KDF541 pHSG575 
fhuATEV site 113-119. In lanes 6 and 7, I ran purified FhuA and TEV protease respectively. Sample in lane 5 
is from nonpermeablized cells. In lanes 1 to 4 are cells from permeablized cells with TEV protease 
(Lanes 3, 4) and without protease (Lanes 1, 2,). The TEV protease bands can be seen in lanes 3 and 4. 
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Figure 24. Western blot showing the proteolysis of periplasmic substrate, MBP-TEV site-PhoA 
by introduced TEV protease. CC118 with (lanes 1-4) and without (lanes 5-8) plasmid pMER1 
(expressing MBP-TEV site-PhoA fusion) were grown overnight in LB and inoculated into complete 
MOPS medium and grown until the culture reached stationary phase. Acetate was used as a carbon 
source for the MOPS culture to avoid catabolite repression of expression from pMER1. Bacteria were 
permeablized and TEV protease was introduced into the periplasm (lanes 1,2,5,6).  After washing, the 
cells were suspended in MOPS medium containing dimercaptopropanol. Fc was added to samples in 






and processed for western blot. Serum containing the primary antibody, polyclonal rabbit anti-PhoA Ig 
and 125I-Protein A was used for the radioimmunoblot. 
Proteolysis of control substrate by expressed TEV protease 
In order to test the activity of the TEV protease in our strains, I transformed 
bacteria CC118 with plasmids, pCC1 (encoding the enzyme, MBP- TEV protease) and 
pMER1 (encoding the substrate, MBP-TEV site-PhoA). Expression of MBP-TEV 
protease was induced with IPTG. MBP-TEV site-PhoA expression was induced with 
arabinose. The expression of the two fusion proteins results in the cleavage of the 
substrate protein by the TEV protease. The coexpression (Figure 25) delivered 
slightly more proteolytic activity than permeablization (Fig 24) as evidenced by the 
increased cleavage (~50% of total substrate protein) of the fusion protein.  The 
addition of even 3 µM Fc, the natural ligand for FhuA did not affect the proteolysis. 
The carbon source acetate reportedly induces catabolite derepression and 
hence was used during induction (Oh 2002). Glucose was used in specific cases as a 
repressor (see Fig 21 legend). With coexpression, the observed proteolysis can happen 
in the periplasm as well as the cytoplasm. This may explain why there is increased 
cleavage of the substrate with coexpression than with periplasmic introduction. 
Alternatively, this may just result from a higher concentration of the protease in the 
former case. 
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Figure 25. Western blots showing the degradation of periplasmic substrate by coexpressed TEV 
protease. Bacteria were grown overnight in LB and inoculated into complete MOPS medium and 
grown until the culture reached stationary phase. The bacteria were harvested by centrifugation and 
suspended in fresh MOPS medium. IPTG (samples in lanes 2-4, 6-8, 10-12 and 14-16) and arabinose 
(samples in lanes 3&4, 7&8, 11&12 and 15&16) was added to induce the expression of the enzyme and 
the substrate fusion proteins respectively. Fc was added to cultures (in lanes 4, 8, 12 and 16) to check 
for any effect on the proteolysis (inhibition) by the FhuA ligand. The carbon source in lanes 1, 5, 9 and 
12 was glucose to repress any expression of MBP-TEV protease fusion. All the other cultures 
contained acetate as the source. The cultures were shaken at 37°C for 3 hours. Lanes 1-4 contain 
samples from the host strain CC118 with no plasmids. In lanes 5-8 are samples from CC118 expressing 
the enzyme, MBP-TEV protease fusion protein (from plasmid pCC1) only and in lanes 9-12 are those 
from bacteria expressing the substrate, MBP-TEV site-PhoA fusion protein (from plasmid pMER1) 
alone. Samples from CC118 coexpressing the enzyme and the substrate fusion proteins were run in 
lanes 13-16. The coexpressed enzyme cleaves the expressed substrate. Serum containing the primary 
antibody, polyclonal rabbit anti-PhoA Ig and 125I- Protein A was used for the radioimmunoblot. The 
arrows indicate bands corresponding to PhoA generated by the proteolysis. 
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Control substrate in the OM 
The control substrate MBP-TEV site-PhoA is expressed in the periplasm. The 
peptidoglycan layer in gram-negative bacteria is linked to the OM by lipoprotein 
moieties. The murein layers the periplasmic face of the inner leaflet of the OM. 
Demchick and Koch (996) estimated that this multilayered sieve has a pore diameter 
of about 2.06 nm and is freely permeable to globular proteins, weighing about 22 to 
25 kilodaltons. This limit is only a rough estimate and the authors reiterate that even 
proteins as big as 50 kilodaltons may still pass through the layer. The molecular 
weight of the purified TEV protease is 29000. The MBP-TEV protease fusion weighs 
approximately 60,000. This raises the question whether protein targets in the OM are 
accessible to TEV protease.   
In order to test whether the protease can attack targets in the OM, we 
constructed a FepA-TEV site-PhoA fusion. Murphy et al. (1989) showed that FepA-
PhoA fusions containing more than the first 210 amino acids of FepA localize to the 
OM. Since the fusion protein contains the entire length of FepA, it will localize to the 
OM. 
Expression of FepA-TEV site-PhoA  
KDL118 (CC118fepA-phoA-) hosting the plasmid pFTPc failed to grow in 
iron deficient MOPS medium. However, KDL118 expressing other FepA-PhoA 
fusions were grown successfully in T medium (Murphy 1990). Therefore, I grew the 
bacteria KDL118 in T media. Although OKN3 expresses no wild type FepA, the 
western blot revealed a FepA band when the bacterium carries pFTPc (Lane 5 and 
lane 1a in figure 26). No expression of the fusion protein was detected in KDL118, 
although it expresses wild type FepA from pITS23 (lane 2, figure 26). This suggests 
that the fusion protein is unstable. In figure 26, lane 3 shows that the FepA 710::PhoA 
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fusion protein (Murphy 1989) is expressed from KDL118. This indicates that the 
instability of FepA-TEV site-PhoA is probably not a result of culture conditions. The 
FepA band in lanes 5 and 1a appears to be the full-length polypeptide. This suggests 
that the fusion protein is getting cleaved at or around the TEV site. However, no TEV 
protease was present in the system. The cleavage may be due to autolysis or other 
cellular proteases. 
Proteolysis of OM substrate 
I tested the ability of introduced TEV protease to cleave the FepA-TEV site-
PhoA fusion protein. Since the protein is unstable and only a faint band was seen even 
without the protease, no specific cleavage could be detected (Figure 26a). 
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Figure 26. Expression of FepA-TEV site-PhoA fusion protein. Bacteria were grown in iron deficient 
MOPS medium and whole cell lysates of the cultures were resolved with SDS-PAGE and mouse anti-
FepA antibody, mab41 (Left) or mab 45 (Right) was used for western blotting. The blots were 
developed colorimetrically. From left to right, the lane order is sample from KDL118, KDL118 + 
pITS23 (fepA+), KDL118 + pFP710 (fepA1-710-phoA fusion), KDL118 + pFTPc (FepA-TEV site-
PhoA fusion), OKN3 + pFTPc (FepA-TEV site-PhoA fusion, lane 5 in left figure, lane 1a in right 
figure) and Benchmark prestained protein marker (Invitrogen ®), lane 2a). 
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Figure 26a. Proteolysis of OM substrate by periplasmic TEV protease. E. coli OKN3 expressing 
pFTPc was grown in iron deficient MOPS medium. The cells were harvested and either left untreated 
(lane 5) or permeablized with (lanes 1,2) or without (lanes 3, 4) TEV protease. The cells were then 











whole cell lysates of the cultures were resolved with SDS-PAGE and mouse anti-FepA antibody, mab 
45 (Right) was used for western blotting. The blots were developed colorimetrically. The fusion protein 
is barely visible in lane 4 (not seen in the photograph). Even in the absence of the TEV protease, the 
fusion protein appears to be cleaved to give off FepA. 
Expression of FepA-TEV site-PhoA in protease deficient strains
The control substrate was unstable in our regular strains. We therefore tried to 
express the construct in strains, SF120 and SF130 deficient in multiple cellular 
proteases (Table 3). The strains were a gift from George Georgiou. Although the 
genotype of these strains does not list any mutations in the fepA gene, I found that the 
strains were resistant to colicins B and D. The strains were sensitive to colicin M. It is 
not clear what alterations are in fepA. The fact that both SF120 and SF130, its 
derivative carries the fepA- phenotype suggests that this is a stable change. The strains 
contain a cassette of a chloramphenicol resistance gene inactivating the protease gene. 
The plasmid vector, pHSG575 also carries the cat gene (chloramphenicol 
acyltransferase). This overlap interfered with the selection of pFTPc transformed 
SF120 or SF130. I tried serial passage in chloramphenicol-free medium to make the 
strains sensitive to the antibiotic. Even after five passes, the bacteria retained the 
resistance gene. More passes may be required before the resistance is lost. However, 
the effects of such a loss on the ptr- genotype are unknown. 
I tried to select for the transformed bacteria with very high concentrations of 
the bacteria. However, even a 250 µg/ml concentration of chloramphenicol (more 
than 100 times the minimum inhibitory concentration (MIC)) did not inhibit the 
growth of the parent strains. Alternatively, I tried to express the fusion protein in 
pUC18 plasmid vector with ampicillin resistance without success. 
Proteolysis of Fhu targets by introduced TEV protease 
I was not able to observe the cleavage of FhuA targets by permeablization or 
coexpression approaches. X1E2, the anti-FhuA antibody recognizes an epitope on the 
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N domain of FhuA. This epitope is located between amino acid 98 and 101. The TEV 
sites are located on the FhuA amino acid sequence such that proteolytic degradation 
of the protein would give rise to a smaller N-terminal fragment and a larger C-
terminal fragment. For FhuATEV site 71-77, the proteolysis will give rise to a C-
terminal fragment, which will retain the epitope for X1E2. Western blots with X1E2 
should reveal a truncated FhuA band if proteolysis occurs. For the other two FhuA 
derivatives with TEV sites at amino acid location113-119 and 136-142, X1E2 will be 
unable to recognize the C-terminal fragment as the epitope will be a part of the N-
terminal fragment. 
The molecular weight of the largest N terminal fragment with the latter 2 
mutants would be less than 15,510. We use 0.45 µM pore size nitrocellulose 
membranes (Protran) for our western blots. Polypeptides of this length are routinely 
observed on such membranes in our laboratory. Since the membranes are 
multilamellar structures, they are expected to bind even the smaller polypeptide 
fragments. However, in order to exclude the possibility that the smaller fragments 
pass thorugh the membranes, I performed the blots using 0.2 µM pore size 
membranes. However, I did not observe any bands such as might arise due to specific 
TEV protease mediated proteolysis. Further, periplasmic proteases may digest the N 
terminal fragments as they arise. Since I did not have access to an antibody 
recognizing an epitope on the C domain, I was unable to observe the larger C terminal 
fragment on western blots. 
Attempts were made in our laboratory to prepare a monoclonal antibody 
against the C domain of FhuA by immunizing mice with purified FhuA. However, 
most of the clones produced antibody directed against epitopes in the N domain of 
FhuA. Two of the isolates appeared to be directed against FepA epitopes. This may be 
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due to cross reactivity or heterophilic generation or maybe due to contamination of 
our FhuA preparation with FepA. Moreover, numerous species of E. coli colonize the 
murine gut. This may explain the origin of FepA specific clones in our preparation. 
Together, these factors forced me to rely on observing the disappearance of FhuA 
bands as an indicator of proteolysis for TEV site mutants FhuATEV site113-119 and 
FhuATEV site136-142. 
Figure 27 depicts the immunoblot of the apparently successful 
transport/proteolysis experiment. We see a near complete disappearance of the FhuA 
band in lane 11 (arrow). 
However, subsequent similar permeablization experiments did not match these 
results. In light of the possible hindrance from peptidoglycan (see above), I introduced 
both TEV protease and lysozyme into the periplasm of bacteria expressing FhuATEV 
site targets. The cell wall of the bacteria, LPS and OM shield the murein from 
digestion by extraneous lysozyme. If introduced into the periplasm, the enzyme is 
then able to digest the peptidoglycan. However, as seen in figure 28, no cleavage of 
the FhuA targets is observed for all three TEV site constructs. Fig 24 depicts the 
coexpression proteolysis experiment. No difference is observed between lanes 
containing wild type FhuA and FhuATEV site 113-119.
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Figure 27. Proteolysis of Fhu targets by introduced TEV protease. E. coli KDF541 expressing wild 
type FhuA (lanes 2-6) and FhuATEV site 113-119  from pHSG575were untreated or permeablized (3-6, 8-11) 
with (5,6 and 10,11) or without (3,4 and 8,9) TEV protease. Subsequently, the cells were incubated 
with (4, 6 and 9, 11) or without Fc. Whole cell lysates were resolved on SDS-PAGE and 
immunoblotted with Mouse anti-FhuA monoclonal antibody (X1E2) and Rabbit anti-TEV protease 
antibody (Michael Ehrmann). The western blots were developed colorimetrically. The arrow over lane 
11, points to the near complete absence of the FhuA protein band.  
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Figure 28. Protease accessibility assay with FhuA and its TEV site derivatives. E. coli MB97 
(fhua) hosting plasmid pHSG575 expressing wild type FhuA (lanes 1-3), FhuA with TEV sites at  71-
77 (lanes 4-6), 113-119 (7-9) and 136-142 (10-12) were either untreated (lanes 1, 4, 7 and 10) or 
permeablized and TEV protease and lysozyme introduced into the periplasm (all other lanes ). The cells 
were subsequently incubated with (lanes 3, 6, 9 and 12) and without (2, 5, 8 and 11) Fc. Whole cell 
lysates were resolved by SDS-PAGE and western blots performed with mouse anti-FhuA antibody, 
X1E2. No cleavage of the FhuA band is observed in any of the lanes. In lane 13, Benchmark prestained 
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Figure 29. Western blot showing the coexpression of FhuA derivatives and the MBP-TEV 
protease fusion by E. coli KDF541. Bacteria were grown overnight in LB and inoculated into 
complete MOPS medium and grown until the culture reached stationary phase. The bacteria were 
harvested by centrifugation and suspended in fresh MOPS medium with no glucose or acetate. IPTG 
was added to induce the expression of the protease fusion protein (in lanes 1, 3, 5, 6, 8 and 10) and the 
cultures were shaken at 37°C for 3 hours. DTT was also added to all the cultures to support protease 
activity. Fc was added to samples in lanes 6 to 10 to allow transport by FhuA derivatives. In lanes 1 
and 6 are samples from KDF541pCC1 expressing only the fusion protein. Lanes 2, 3, 7 and 8 carry 
samples from KDF541pUC18fhuA expressing wild type FhuA with (2 & 7) and without (3 & 8) the 
MBP-TEV protease fusion. Similarly lanes 4, 5, 9 and 10 carry samples from KDF541pUC18fhuATEV 
site 113-119. A mixture of X1E2 (Mouse anti-FhuA Ig) and Rabbit anti-TEV protease Ig were used for the 










Experiments in FhuA target proteolysis 
I attempted several variations in the protocols to increase the activity of the 
TEV protease and achieve FhuA target proteolysis. These included changes in the 
medium, reaction conditions and the chemical composition of the buffers. 
Sulfhydryl agents. TEV protease is a cysteine protease. In cysteine proteases 
like Papain, the active site contains a thiolate imidazolium pair (Polgar 1974). The 
cysteine of the dyad is sensitive to oxidation. Therefore, thiol reductive compounds 
are added to the proteolysis reaction mixture. These include compounds like 2-
mercaptoethanol (β-ME), dithiothreitol (DTT) and dimercaptopropanol. In the past, 
we (Bo Jin and I) have found that we can add β-ME and DTT up to a concentration of 
1 mM to bacterial cultures without any deleterious effects on cell growth. I therefore 
added 1 mM DTT to the reaction mixture to maintain the active site sulfhydryl in the 
reduced state. As expected, I found no difference in cell survival or protein 
expression. However, these agents did not affect the enzyme activity and no cleavage 
of the FhuA targets was detected. 
Reaction conditions. The physiological temperature for TEV protease activity 
is ~30°C. I tested the proteolysis at both 30 and 37 degrees. TEV protease functioned 
comparably, if not better at 37°C in our experiments. Changes in centrifugation 
speeds or temperature had no impact. Changes in the washing procedure like the 
frequency of washes and the temperature of the buffers did not influence the outcome.
Medium. For co-expression experiments, which involved bacteria with 
multiple plasmids, I found that overnight cultures in LB medium required at least 1% 
glucose as a supplement for proper cell growth. I also tried different defined media for 
the subculture and the proteolysis. However, the different defined media did not affect 
the proteolysis except the cell yield of the subcultures. 
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TEV protease is inhibited by high concentrations of copper and zinc ions. 
MOPS medium usually includes solutions containing copper and zinc ions. However, 
these ions are present at much lower concentrations in MOPS medium. Nevertheless, 
I prepared MOPS medium without Copper and Zinc. However, use of this altered 
MOPS medium did not produce visible proteolysis. 
In order to remove even trace amounts of copper and zinc, I added chelators 
that sequester Copper and Zinc. In vitro proteolysis with TEV protease usually 
involves the use of EDTA (Ethylenediamine tetraacetic acid). EDTA is not only a 
chelator of zinc and copper ions, but also sequesters magnesium ions. The structural 
integrity of the lipopolysaccharide and in turn the cell wall of E. coli depends on the 
crosslinking salt bridges formed by magnesium ions. Therefore, we decided against 
adding EDTA as a chelator. The search of literature for a more specific chelator 
yielded dimercaprol (Dimercaptopropanol, British anti-Lewisite, BAL). Dimercaprol 
also has the added advantage of being a sulfhydryl reducing agent. I therefore used 
dimercaprol as a dual agent in our reactions. D-penicillamine is another chelator of 
these two metal ions. However, it did not produce any detectable results. None of 
these modifications led to detectable proteolysis of FhuA. 
Buffers. I originally employed the permeablization technique described in 
Zgurskaya et al. (1999), which uses permeablization buffers with high sucrose 
concentrations. The original protocol devised by Brass et al. employed high 
concentrations of calcium. The sucrose technique was only a modification suggested 
for proteins affected by calcium. Therefore, I switched to sucrose free 
permeablization buffers (see above). However, no difference was seen between 
samples that were treated with the two different buffers.
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Enzyme concentration. I tried to increase the concentration of the TEV 
protease in the experiments. Even increasing the amount of TEV protease introduced, 
from 10 units to 50 units and then 200 units per 109 cells failed to show hydrolysis of 
the FhuA targets.  
Protein expression. I used rifampicin at a concentration of 200 µg/ml to block 
bacterial transcription. This enabled us to study the effects of the proteolysis on only 
the protein molecules that are fully folded and localized. However, this did not change 
the outcome in that I was not able to detect any proteolysis.  
Oxamates. Dougherty et al. (1988) reported that oxamates inhibit the activity 
of cysteine proteases at concentrations above 1 µM. Fc, the natural ligand for FhuA is 
a hydroxamate ferric siderophore. It is probably transported intact into the cytoplasm 
of the cells. Nevertheless, I tested the activity of the TEV protease on the control 
substrate in the presence of Fc. I found that concentrations as high as 3 µM did not 
affect the proteolytic activity.
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Fluorophore labeling of residues in the N domain
Selection of fluorophores 
I selected the thiol reactive fluorophore conjugate, FM (Molecular probes, 
Invitrogen) to label the introduced cysteines in vivo. Several considerations dictated 
the selection of the fluorophore. Cao et al. (2003) described the optimal conditions for 
labeling mutant FepA proteins in vivo with the FM. The OM contains water-filled 
channels that allow the free diffusion of molecules smaller than 600 Da (Nikaido and 
Vaara 1985). Specifically, the protein OmpF provides a 7 by 11 Å eyelet (Cowan 
1995). From sugar diffusion studies, the estimated diameter of the pore is about 12 Å. 
The molecular weight of FM is 427 (Molecular probes). Further, the largest diameter 
of the fluorescein molecule is about 9 Angstrom. The conjugate is therefore small 
enough to traverse the OM (OM) of the bacterium and enter the periplasm. We do not 
expect FM to travel through FepA, unless a conformational change in the N domain 
creates a channel. 
In addition to FM, I also used ALEXA Fluor 488 C5-maleimide (AM, 
Molecular probes, Invitrogen). ALEXA Fluor 488 is a derivative of fluorescein of 
molecular weight 720.66. The crystal structure of AM is not available. The larger size 
of this molecule suggests that it will not traverse the OM. However, the structure of 
this molecule resembles fluorescein and its larger weight may not necessarily increase 
its largest diameter in solution. 
Entry of fluorophores into the periplasm 
In order to assess the ability of the fluorophores to enter the periplasm, I tested 
the labeling of cysteines introduced in lipid-deficient derivative of AcrA (Zgurskaya 
1999). The derivative is present in the periplasm and is free of cysteines. Therefore, 
the mutation A15C (Ip 2003) introduces an unbonded cysteine. 
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I tested the labeling of AcrAA15C expressed from pUZ11 (pUC18 derivative) 
in AG100A. While wild type AcrA was unmodified, both FM and AM modified 
AcrA A15C (figure 30) indicating that the agents enter the periplasm. The strain and 
the relevant plasmids were a gift from Helen Zgurskaya (Department of Chemistry & 





Alexa Fluor® 488 C5-maleimide 
(AM)
Formula C24H13NO7 C30H25N4NaO12S2
Molecular weight 427.37 720.66
Structure
Table 11. Comparison between FM and AM.  
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Figure 30. Labeling of AcrA by FM and AM. AG100A expressing AcrA wild type (lanes 1 and 3) or 
AcrA A15C (lanes 2 and 4) were labeled with 65 µM FM (lanes 1 and 2) or AM (lanes 3 and 4) for 30 
min at 37°C. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was scanned 




Location of the introduced cysteines 
The amino acid sequence of the FepA polypeptide contains two cysteines at positions 
487 and 494. Prior research (Liu 1994) established that these cysteines form a 
disulfide bond. Accordingly, neither of these two cysteines are labeled by 
fluorophores (Cao 2003, figure 31). We selected residues for mutagenesis based on 
their crystal structure coordinates. Glycine 54 is located on the lateral surface of the N 
domain away from the hinge in FepA. Glycine 54 also initiates loop NL1 of FepA. In 
the crystal structure, it is not visible from the surface opening of the barrel and barely 
observed through the periplasmic opening. Therefore, the residue is apparently 
inaccessible from the cell surface or the periplasm. In close proximity to glycine 54 is 
glycine 565 in the barrel wall. The side-chains of  its flanking amino acids, leucine 
566 and glutamate 564 point towards the membrane bilayer in the crystal structure. 
Since the residues are in β strand 16 of the barrel, the side chain of G565C probably 
points inwards into the lumen of the barrel. The reverse orientation will likely disrupt 
the beta strand and compromise the protein’s structure. 
At the top of the N domain, tryptophan 101 is located in NL2. FepAW101C is 
labeled with FM (Cao 2003) implying that this residue is freely accessible from the 
cell surface. At the periplasmic face of the N domain is residue isoleucine 14. 
Isoleucine14 is also a member of the ‘TonB box’. It is located in close apposition to 
the barrel, specifically to residue glycine 300. Daniel Scott prepared FepAG54C as 
part of a study involving disulfide bond formation. For a similar objective, Paul 
Warfel constructed FepAI14C and FepAG300C. Bo Jin and I constructed 
FepAW101C for the in vivo labeling study described above (Cao 2003). Li Ma 
introduced the mutation G565C in FepA.  
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C-domain N-domain
Figure 31. Target residues for cysteine mutagenesis. The residues were selected based on their 
location in the crystal structure of FepA. The views are in the plane of the lipid bilayer with the cell 
exterior on top and the periplasm at the bottom. The protein backbone of both N- and C- domains is 
depicted in grayscale. On the left, the C domain is shown in slab mode to reveal the location of glycine 
565. Glycines 54, 300 and 565 are depicted in blue. Isoleucine 14 is depicted in green, threonine 51 in 
orange and tryptophans 101 and 153 are depicted in pink. One of the native cysteines, 494 is depicted 
in yellow. The other cysteine, 487 was not mapped in the crystal structure. Tryptophan 153 is shown to 
indicate the position of the hinge between the N domainand the C-domain β- barrel. 
FepA Diameter of halo in mm
OKN3 OKN13
-- 0 0







Table 12. Siderophore nutrition assay of cysteine substitution mutants. The diameter of the zone of 
growth (halo) of bacteria around the disc containing the ferric siderophore is expressed in millimeters. 
Differences are also noted in the opacity of the halos which reflect the density of the bacterial growth. 
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Siderophore nutrition assay. 
I tested the ability of the protein constructs to transport FeEnt. All the mutant 
proteins transported FeEnt into OKN3. As expected, none of the constructs supplied 
iron to strain OKN13 lacking TonB. FepAW101C produced a lower density of cell 
growth than wild type FepA (Table 12).
Colicin killing
All the mutant proteins conferred sensitivity on OKN3 to colicins B and D. 
None of the proteins was active in OKN13. FepAW101C was only 10% as active as 
wild type FepA in this assay (Table 13). 
Protein expression 
All the mutant constructs expressed FepA from its natural promoter (Figure 
32). 
Labeling with FM 
Initial fluorophore labeling was performed with FM and the FepA proteins 
expressed in OKN3. For samples labeled with FM and also AM, the best results were 
obtained by directly scanning the wet gel for fluorescent bands (STORM scanner). 
Transferring the bands onto nitrocellulose before scanning led to a loss of sensitivity 
(Figure 33). Although we had antibodies against fluorescein, immunoblotting did not 
give greater sensitivity and reduced specificity. 
I experimented with different concentrations of FM. Of the concentrations that 
I tried, 65 µM gave the best labeling at FepAG54C (Figure 33).  I observed no 
labeling with wild type FepA (Figure 34). This is consistent with earlier reports (Cao 
2003). 
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Colicin sensitivity titer as percent wild type titers
FepA protein OKN3 OKN13
B D B D
-- 0 0 0 0
Wild type 100 100 0 0
I14C 100 100 0 0
T51C 100 100 0 0
G54C 100 100 0 0
W101C 10 10 0 0
G300C 100 100 0 0
G565C 100 100 0 0
Table 13. Colicin sensitivity of cysteine substitution mutants. Titers correspond to the reciprocal of 
the maximum dilution of the colicin that clears the bacterial lawn. Results are expressed as a 
percentage of the titers calculated for killing of OKN3/pITS23 expressing wild type FepA. 
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Figure 32. 125I- Protein A immunoblot profiling the expression of FepA derivatives. Bacteria were 
grown in iron deficient MOPS medium and harvested by centrifugation. The cell pellets were lysed and 
resolved by SDS-PAGE. The protein bands were electroeluted onto nitrocellulose membranes and a 
radioimmunoblot was performed. Mab45, a monoclonal antibody that recognizes an epitope on the C 
domain was used as the primary antibody. All the constructs were expressed in OKN3. The picture is a 
composite of pictures taken of immunoblots performed for each mutant construct. The samples in strips 
1to 7 were wild type FepA, FepA I14C, T51C, G54C, W101C, G300C and G565C. 
FepA
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Figure 33. Detection of FM labeled FepAG54C. FepAG54C expressed in from plasmid pHSG575 in 
KDF541 were labeled with increasing concentrations of FM. From 
samples in lanes 1 to 4, the concentrations employed were 1.3 µM, 6.5 µM, 13 µM and 65 µM 
respectively. The bands were detected by scanning the gel (left) or by radioimmunoblotting with rabbit 
serum containing anti-fluorescein antibodies (anti-BSA-fluorescein iodoacetamide Cao 2003) and 125I-
Protein A. The arrow indicates labeled FepAG54C.
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Figure 34. Labeling of wild type FepA by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 
and 8) expressing wild type FepA from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 
2, 3 and 4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were pre-incubated with 10 µM 
FeEnt at 0°C for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel 
was scanned for fluorescence in a STORM SCANNER (Molecular Dynamics). In lane 9 is FepA 




FepAW101C showed strong labeling (Figure 35). In the crystal structure, the β
carbon of tryptophan 101 is located at a distance of 9.56 angstrom from the β carbon 
of cysteine 494 (Figure 36, Buchanan 1999). Cysteine 487 is not described in the 
crystal structure. However, since the disulfide does form (Liu 1994), it is probably in 
close proximity to the other residues. The resultant sulfhydryl triad can possibly form 
one of three disulfide bonds namely C487-C494, W101C-C487, or W101C-C494. 
This will leave the odd cysteine to be labeled by FM. The fact that none of the other 
cysteine mutants exhibited this pattern indicates that this shuffling of the disulfide 
bond does not happen during maturation of the protein.  
With wild type FepA, the presence or absence of β-mercaptoethanol does not 
affect the migration of the protein on SDS-PAGE. This is because the loop subtended 
by disulfide formation in the native polypeptide is only 7 amino acids long. This does 
not visibly alter the extended conformation of the solublized protein. However, if the 
disulfides form between W101C and either of the natural cysteines, the loop is 
between 386 to 393 residues long. Such a looped conformation presumably affects the 
gel migration of the SDS- solublized polypeptide.  In the presence of the reducing 
agent, labeled FepAW101C migrates as a single band. In the absence of the thiol 
reagent, labeled FepAW101C migrated as two different bands. The larger size of the 
aberrant band indicates that this is probably not a result of degradation or protein 
instability. Theoretically, the protein may get labeled at any of the three cysteines. 
The smaller band migrates at the level of other labeled FepA proteins. One 
explanation is that the larger band is the protein with the loop formed either by 
W101C-C487 or W101C-C494 bonding and the smaller is that with the natural C487-
C494 cystine. The latter presumably represents the population labeled at residue 101. 
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This implies that the looped polypeptide migrates slower despite a presumably more 
compact conformation.  
The presence of only two rather than three labeled bands raises another 
possibility. Neither of the bands may have label attached to W101C. Instead, the 
protein may be labeled only at C487 or C494. The labeling of FepAW101c in OKN13 
(tonB-) even in the presence of FeEnt supports this conclusion. Such a concentration 
will saturate the binding site and also induce closure of the surface loops of FepA. It 
is expected that such closure would prevent FM from accessing W101C. Two factors 
confront this conclusion. The difference in the gel migration caused by the addition of 
only seven amino acids to the loop is surprising. Even more intriguing is the 
migration of the smaller at the same rate as native FepA. This model suggests that 
W101C is not accessible to fluorophores. This is also consistent with the absence of 
labeling at S211C (Cao 2003). In other words, the interior of the barrel is not 
accessible to fluorophores. 
I also observed strong labeling of I14C (Figure 38). In contrast, I observed 
only weak labeling of T51C (Figure 39), although threonine 51 is clearly visible on 
the periplasmic face of the N domain in the crystal structure. The gamma carbon in 
the side chain of this threonine points towards the barrel (Buchanan 1999). The 
sulfhydryl group of the substituted cysteine may take a similar orientation and stearic 
hindrance may hinder its modification. Alternatively, the cysteine may assume a 
buried conformation. Threonine 51 is not part of a helix or a β sheet. The amino acid 
and its substitute are probably not subject to the constraints of these secondary 
structures. Therefore, it is not clear what alterations that this mutation will make to the 
local conformation and what effects will result. 
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The residue glycine 54 is on the lateral surface of the N domain. I found that 
FM labeled G54C (Figure 40). Glycine 54 is barely visible from the periplasm and 
invisible from the surface in the space filled representation of FepA’s crystal 
structure. Yet, it was accessible to modification. 
Among the residues substituted in the C domain, G300C was weakly labeled 
with FM (Figure 41), whereas G565C was not modified (Figure 42), despite its 
proximity to glycine 54. In light of the protein’s wild type sensitivity to colicins B and 
D and its ability to transport FeEnt, it is imaginable that the mutation G565C did not 
disrupt FepA structure. This supports the conclusion that the substitution did not 
compromise β strand 16. In the absence of any such disruption, the sulfhydryl group 
of the cysteines side chain is not modified despite its location in the lumen. This 
suggests that the fluorophore does not enter this part of the barrel but that G54C is 
labeled when the residue and the N domain moves out of the barrel. Such movement 
may be directed towards the surface or the periplasm. 
The same labeling pattern was found when the reaction was performed at 37 
°C or 0°C. 
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Figure 35. Labeling of FepAW101C by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 
and 8) expressing FepAW101C from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 2, 
3 and 4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were incubated with 10 µM FeEnt 
at 0°C for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was 
scanned for fluorescence in a STORM SCANNER (Molecular Dynamics).  
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Figure 36. Detection of FM-FepAW101C in the presence and absence of sulfhydryl reagents.
KDF541expressing FepAG54C (lane 1) and FepAW101C (lane 2) from pHSG575 were labeled with 
65 µM FM for 30 min at 37°C. The cells were lysed in sample buffer without adding 2-
mercaptoethanol and resolved by SDS-PAGE. The gel was scanned for fluorescence in a STORM 




Figure 37. Distance between W101 and C494 in the crystal structure. 
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Figure 38. Labeling of FepAI14C by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 and 
8) expressing FepAI14C from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 2, 3 and 
4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were incubated with 10 µM FeEnt at 0°C 
for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was scanned for 
fluorescence in a STORM SCANNER (Molecular Dynamics).  
FM-FepAI14C
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Figure 39. Labeling of FepAT51CC by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 
and 8) expressing FepAT51C from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 2, 3 
and 4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were incubated with 10 µM FeEnt at 
0°C for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was 
scanned for fluorescence in a STORM SCANNER. 
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Figure 40. Labeling of FepAG54C by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 and 
8) expressing FepAG54C from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 2, 3 and 
4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were incubated with 10 µM FeEnt at 0°C 
for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was scanned for 
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Figure 41. Labeling of FepAG300C by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 
and 8) expressing FepAG300C from pHSG575 were labeled with 65 µM FM for 30 min at 37°C (1, 2, 
3 and 4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were incubated with 10 µM FeEnt
at 0°C for 10 min. The cells were lysed in sample buffer and resolved by SDS-PAGE. The gel was 
scanned for fluorescence in a STORM SCANNER (Molecular Dynamics).  
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Figure 42. Labeling of FepAG565C by FM. OKN3 (lanes 1, 3, 5 and 7) and OKN13 (lanes 2, 4, 6 
and 8) expressing FepAG565C from pHSG575 were labeled with 65 µM 
FM for 30 min at 37°C (1, 2, 3 and 4) or 0°C (lanes 5, 6, 7 and 8). Samples in lanes 3, 4, 7 and 8 were 
incubated with 10 µM FeEnt at 0°C for 10 min. The cells were lysed in sample buffer and resolved by 
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Figure 43. Labeling of wild type FepA by AM. The data was obtained as detailed for FM above. 
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Figure 45. Labeling of FepAI14C by AM. The data was obtained as detailed for FM above. 
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Figure 47. Labeling of FepAT51C by AM. The data was obtained as detailed for FM above. 
However, labeling was only performed at 37°C. 
. 
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Figure 48. Labeling of FepAG300C by AM. The data was obtained as detailed for FM above. No 
labeling of FepA G300C is observed in any of the four lanes. 
AM-FepA mutant
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Figure 49. Labeling of FepAG565C by AM. OKN3 (lanes 1, 3) and OKN13 (lanes 2, 4,) expressing 
FepA G565C from pHSG575 were labeled with 10 µM AM for 30 min at 37°C. Samples in lanes 3 and 
4 were pre-incubated with 10 µM FeEnt at 0°C for 10 min. The cells were lysed in sample buffer and 
resolved by SDS-PAGE. The gel was scanned for fluorescence in a STORM SCANNER (Molecular 
Dynamics).  No labeling of FepA G565C is observed in any of the four lanes. 
Figure 50. Distance between isoleucine 14 and glycine 300 in the barrel wall. 
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Labeling with AM 
I tested the ability of AM to label the cysteines of FepA in OKN3. The 
fluorophore did not label wild type FepA (Figure 43). But it modified W101C (Figure 
44). However, this may be subject to the same considerations as FM labeling (see 
above).
G54C is also labeled (Figure 46). G565C is not labeled (Figure 49). The 
labeling of G54C and not G565C by AM suggests that the fluorophore gains access to 
the former residue when it is outside the barrel. 
AM labeled I14C poorly (Figure 45) and did not label G300C (Figure 48). The 
β carbon of isoleucine 14 is 4.74 Angstrom away from the alpha carbon of glycine 
300 in the barrel wall (Figure 50). Stearic hindrance may block or reduce labeling at
these sites. Unlike FM, AM did not modify T51C (Figure 47). The difference in 
labeling with FM and AM at these three sites suggest that stearic factors influence the 
reaction with fluorophores. 
No difference was noted in the labeling pattern between conducting the 
labeling at 37°C or 0°C. T51C was not tested at 0°C. 
Labeling and TonB 
The next consideration was the relationship between labeling and the presence 
or absence of the cofactor TonB. All the different FepA constructs are expressed in 
OKN13 at wild type FepA levels. 
The labeling of G54C in OKN13 was sensitive to the temperature of the 
reaction. While the labeling of G54C in OKN13 resembled OKN3 at 37°C, when 
labeled at 0°C, the intensity of labeling in OKN13 decreased. FepAG54C also showed 
the difference with AM, albeit to a lesser degree. Labeling at other residues did not 
show this temperature dependence. The absence of tonB in some way affects the 
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labeling at G54C at 0°C.  FepAT51C is not labeled by FM in the absence of tonB. In 
the absence of TonB, T51C apparently does not attain a labeling competent 
orientation. 
Labeling and FeEnt
I compared the ability of the flurophores to modify G54C in the presence and 
absence of FeEnt. The experiment was performed with both OKN3 and OKN13. Both 
FM and AM were tested at 0°C and 37°C. I found that the prior addition of FeEnt 
concentrations as high as 100 µM did not compromise labeling in the transport 
competent strain (Figure 51). The minimum concentration that could be tested with 
the transport competent strains was 10 µM (Table 14). Lower concentrations were 
affected by substrate depletion and transport was not sustained throughout the 
duration of labeling (Newton 1999). The ferric siderophore in the extracellular 
medium was transported into the cell during the reaction and conditions resemble 
experiments conducted in the absence of FeEnt. On the other hand, concentrations as 
low as 1 nM decreased or blocked labeling of G54C in OKN13. The latter strain does 
not allow transport. The Kd of wild type FepA is around 0.2 nM. At subnanomolar 
concentrations, the receptor proteins are not saturated. This scenario leaves a 
population of receptors unbound by FeEnt and open to attack by FM. As the 
concentration of the ligand increases, the receptor proteins become saturated. In this 
situation, the label is not able to attack the target cysteine. This explains why there is a 
difference in the labeling at different concentrations of FeEnt. Similar results were 
obtained with both FM and AM. The same pattern was noted with incubation at 0°C 
and 37°C. The binding of FeEnt blocks labeling at G54C. 
The addition of 10 µM FeEnt did not affect the labeling of W101C by FM or AM. 
Even in the tonB- strain, W101C got labeled. No difference in FM labeling was noted 
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at either temperature of incubation. With G565C, no labeling was detected in the 
presence or absence of FeEnt. This was true of both the fluorophores. The presence or 
absence of tonB or the change in the temperature made no difference. 
With G300C, the addition of FeEnt increased the labeling with FM. This was 
noted in both tonB+ and tonB- situations at both 0°C and 37°C. In contrast, no 
labeling was detected with AM even in the presence of FeEnt. 
With I14C, the addition of FeEnt appeared to increase the labeling by FM 
slightly in the transport competent strain, OKN3. In OKN13, the proteins were 
labeled comparably with and without FeEnt. With AM, the addition of FeEnt 
markedly increased the labeling of I14C in both tonB+ and tonB- strains. The above 
pattern was noted at both the temperatures of incubation.
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Figure 51. Labeling of FepAG54C by FM in the presence of increasing concentrations of FeEnt.
OKN3 (lanes 1-8) and OKN13 (lanes 9-16) expressing FepAG54C from pHSG575 were labeled with 
65 µM FM for 30 min at 37°C. Samples in lanes 1 and 9 were not exposed to FeEnt. Samples in lanes 
2-8 and lanes 10-16 were each incubated with 10-fold increasing concentrations of FeEnt from 0.1 nM 
up to 100 µM at 0°C for 10 min before exposure to the fluorophore. The cells were lysed in sample 
buffer and resolved by SDS-PAGE. The gel was scanned for fluorescence in a STORM SCANNER 













600 0.1 nM 0.06 0.00038 Yes
,, 1 nM 0.6 0.0038 Yes
,, 10 nM 6 0.038 Yes
,, 100 nM 60 0.38 Yes
,, 1 µM 600 3.8 min Yes
,, 10 µM 6000 38 min No
,, 100 µM 60,000 380 min No
Table 14. Duration of FeEnt transport at different concentrations of FeEnt. The Vmax of transport 
of FeEnt by wild type FepA expressed in OKN3 is 160 pmol transported/109 cells/min (Salete Newton, 
Raj Annamalai and Bo Jin). It can be seen that concentrations of FeEnt higher  than 10 µM are required 




Recognition of ferric catecholates
Siderophore receptors differ in their specificities of metal complexes that they 
recognize. From the data observed, it appears that FepA rejects not only the 
hydroxamate Fc but also the dicatecholate ferric agrobactin. Furthermore, it 
discriminates between the three tricatecholate compounds FeEnt, FeTRENCAM, and 
FeCorynebactin. One possible binding mechanism for LGP recognition of ferric 
siderophores is that FepA initially adsorbs hydrophobically iron complexes in a 
nonspecific interaction and then rejects unrecognized metal chelates as the binding 
equilibrium progresses further. However, the complete inability of Fc and ferric 
agrobactin to inhibit 59FeEnt adsorption suggests that no such initial interaction 
happens. The first measurable stage of ferric siderophore binding has specificity, in 
that it was only impaired by ferric catecholate complexes that are structurally similar 
to FeEnt. This specificity likely derives from the aromatic amino acids in the B1 
region of the vestibule mouth. 
The selectivity of FepA for FeEnt provides more information about the 
determinants of ligand recognition. Ent, TRENCAM, and Corynebactin all form 
tricatecholate, hexadentate, octahedral complexes with iron (III), but they differ in 
size and in their chemistry. Unlike FeEnt, which has a trilactone backbone, the 
synthetic compound FeTRENCAM contains three alkyl chains linked to a central 
amine that connect by amide bonds to its dihydroxybenzoic acid groups. Therefore 
FeTRENCAM (604 Da) is smaller than that of FeEnt, and with a pKa of 5 its central 
amine is essentially unprotonated at neutrality. The 50-fold reduction in the affinity of 
FeTRENCAM binding, and 20-fold reduction in the affinity of its transport indicate 
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that the face of its iron center, which is identical to that of FeEnt, is not the only 
determinant of its recognition by FepA. The structural alterations behind the iron 
center impair its binding, relative to that of FeEnt. The six oxygens of the natural 
siderophore's lactone ring provide many potential H-bond acceptors that are absent in 
FeTRENCAM, suggesting a reason for its lower affinity. These data concur with the 
model in which the receptor's loops surround the ferric siderophore at binding 
equilibrium and thereby interact with the backbone. 
Different considerations may explain the partial binding observed with 
FeCorynebactin. Both FeEnt and FeCorynebactin have a cyclic ester backbone, 
formed by serine and threonine, respectively, from which dihydroxybenzoic acid 
moieties project. The latter siderophore also contains glycine spacer groups between 
the backbone and the chelating groups. These differences make FeCorynebactin 
heavier and larger than FeEnt (933 versus 719 Da). Besides its greater mass, the metal 
center of FeCorynebactin has opposite chirality (Λ) to that of FeEnt ( ) and 
FeTRENCAM ( ) (Raymond 2003). However, although FepA recognizes the iron 
center of ferric siderophores, chirality does not govern the receptor-ligand interaction. 
FeEnEnt binds with comparable affinity as FeEnt (Thulasiraman 1998). Thus, the 
rejection of 59FeCorynebactin was surprising and implied that its increased 
dimensions preclude productive adsorption to the receptor. The partial inhibition of 
59FeEnt binding by FeCorynebactin and the nonretention of 59FeCorynebactin by cells 
expressing FepA suggest that the ferric siderophore begins to bind but does not reach 
a stable equilibrium. The larger size of FeCorynebactin may interfere with loop 
closure and hence its passage from B1 to B2. 
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Aromatic amino acids in FepA function
The eleven surface loops of FepA form a large external vestibule through 
which FeEnt enters. The solution of the crystal structure of FepA did not reveal a 
binding site for the siderophore, although the occurrence of an iron-like electron 
density was found in the extremities of the surface loops (Buchanan 1999). However, 
accumulating evidence gathered in the past two years suggests that gated porins are 
not static structures that passively bind and transport their ligands, but instead, they 
may undergo quite extensive changes in conformation during ligand binding and 
subsequent uptake. Indeed, we observed biphasic binding kinetics compatible with the 
existence of either two "passive" binding sites located at the surface and deeper in the 
vestibule, or of a conformational change in the loops that would move the siderophore 
from its initial site to a secondary region of the porin (Payne 1997). 
Evidence for conformational changes in FepA was first obtained by ESR 
(electron spin resonance spectroscopy) analyzes of nitroxide probes attached at site 
E280C (Jiang 1997). By monitoring the mobility of covalently bound nitroxide spin 
labels, the opening and closing of the gated-porin channels during membrane 
transport was visualized in vivo. In vivo cross-linking experiments demonstrated that 
loop7 undergoes dramatic displacement upon ligand binding: it changes from an 
initially open conformation (not revealed in the crystal structure), to a closed version 
(probably similar to that of the crystallized version). This change is not exclusive to 
FepA, as another gated porin, FecA (transporter of ferric citrate), showed major 
conformational changes of extracellular loops 7 and 8 upon ligand binding (Ferguson 
2002). Loop 7 moves as much as 11 A in FecA upon ligand binding. The binding of 
ferric citrate causes conformational changes in the extracellular loops, such that the 
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siderophore becomes solvent-inaccessible. It is likely that such form resembles the 
closed phase of the surface loops of FepA when FeEnt binds.
The distinct chemical nature of the two siderophores, FeEnt and Fc precludes 
the direct extrapolation of those residues subtending the binding site in the Fc-FhuA 
complex to that of FeEnt-FepA. In this scenario, site-directed mutagenesis enables the 
study of the importance of selected amino acids in the structure and function of the 
protein. Single mutation or double substitutions involving the aromatic components of 
two FeEnt binding sites in FepA, Y260, Y272, and F329, severely impaired the 
adsorption of FeEnt (Cao 2000). For Y260A and Y272A, the decreased affinity 
caused comparable decreases in transport efficiency, suggesting that they primarily 
act in ligand binding. However, F329A, as well as R316A in a positive charge cluster 
on the receptor surface, showed greater impairment of transport than binding, 
intimating mechanistic involvement during ligand internalization. Along with the 
position of these aromatic and positive charged residues in the crystal structure of 
FepA, the mutagenesis results suggested the existence of two ligand binding site, with 
aromatic residues mainly in B1 and both aromatic and positive charged residues in 
B2. 
The data presented in this study enables the consideration of the primary role 
of each aromatic residue studied, in the overall function of FepA. Broadly, the effects 
of the mutations can be classified into three major classes. Class I mutations are of 
residues which are primarily involved in binding. The result of their substitution on 
transport derived from their effects on binding. Y472, Y481, Y488 and Y540 belong 
to this class. Among these substitutions, Y481A produced the largest defect namely a 
17-fold increase in Kd and a 18-fold increase in Km. Among these resides, Y481 
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appears to be a major component of the binding site. Its well-exposed location on the 
protein’s surface further supports this conclusion. 
All the aromatic residues, presented here, with the possible exception of 
W101, were selected as putative constituents of the FeEnt binding sites and were 
expected to be primarily involved in the binding interaction. However, Class II 
mutations caused no or only moderate defects on binding but greater results on the 
transport process. These observations suggest that the aromatic residues, in spite of 
their location in the surface loops of FepA, contribute significantly to the transport 
mechanism. These residues may participate in the transmission of conformational 
signals, to initiate the transport sequence, to either the N domain or the β barrel or 
both, or may directly interact with crucial residues, which accomplish the transport 
process. 
Among the residues producing class II defects, Y478 is part of loop 7 of FepA. 
This loop undergoes a large 11 Ǻ translocation upon ligand binding and closes off 
FeEnt from the surface solvent (Scott, Ferguson). The resultant increase in local 
concentration of FeEnt may drive the transport of ligand into the periplasm. The 
considerable increase in the thermal factor of mapped residues distal to L480 in loop 7 
of FepA also suggests that this region of the protein undergoes dynamic transitions 
(Buchanan 1999). Y478A is deeper in the vestibule and may serve as the essential 
anchor for further signaling that will accomplish the transport process, which may 
explain the 500-fold increase in Km of Y478A over the wild type. Other residues in 
this group are amino acids W101 and Y638. In addition to their effects on transport 
Km, they also demonstrate a severe reduction in their capacity of binding. In light of 
their wild type level expression on the surface, this reduction in the capacity of 
binding reflects the functional importance of these residues. One possible explanation 
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is that these residues are key participants in the optimization of the binding site for 
FeEnt. In their absence, the binding site in a majority of the receptor proteins may not 
adopt its functional conformation. Y217 and Y553 are other members of this group. 
The varied location of these residues underscores the multi-determinant nature of the 
binding and uptake process. 
A class III mutation was uncovered with Y495A. The substitution produced 
small defects in the Km of transport but severely reduced the Vmax of the receptor 
protein. FepA Y495A also had a low turnover number of 0.4. The turnover number 
relates the number of molecules transported per minute. The mutation therefore 
affects the rate-limiting step in the transport reaction. 
Of the surface exposed residues in the crystal structure, tyrosines 481, 495 and 
638 are located centrally in the vestibule, whereas residues 217, 540 and 553 are 
located more peripherally. Mutagenesis of the former group of residues caused large 
defects in the binding and/or transport, while mutagenesis of the latter produced 
modest defects. The difference in the location of these residues may explain their 
differential effects on the protein function. Residue 488 falls in an unresolved portion 
of the crystal structure. The location of the nearest resolved residues indicates that 
tyrosine 488 may be well exposed to the surface. However, FepAY488A produced a 
zone of growth very close to that of wild type FepA in the siderophore nutrition assay. 
The presence of the disulfide bond between C487 and C494 and the resultant 
conformational constraints may explain the limited role of Y488 in spite of its 
location. 
Loops of the N domain in FepA function
The N domainloop deletions produced large class II effects.  Their effect on the 
transport process far exceeded the effect on binding. It is noteworthy that the 
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replacement of tryptophan 101 with alanine precluded the calculation of maximal 
velocity of transport, but the deletion in NL2, which also removes tryptophan 101, 
still allowed the same measurements. This underscores the importance of this residue 
to native FepA. In the deletions, the local rearrangements of the protein structure 
especially the truncated loop NL2, apparently allow the protein to compensate. In 
other words, the change in NL2 produces a scenario different from the substitution of 
one of its residues W101 with alanine. 
N domain of ligand gated porins
The N domain of the ligand-gated porins is a novel fold. This globular domain 
occupies the barrel formed by the C domain. Initial studies suggested that this 
structure is less important in the transport of the ferric siderophores (Scott 2001, 
Braun 1999). The authors found that the Km of transport for Fepβ and Fhuβ, the 
proteins without their N domains was similar to that of the full length FepA and FhuA 
respectively. However, later studies have questioned this conclusion. The latter 
suggested that the host strains for these protein constructs produced one or more 
complementing factors that restored activity to the N domain deleted proteins. These 
constructs were shown to be inactive in host strains lacking these complementing 
fragments (Vakharia 2002, Braun 2003). In this study, I repeated some of the 
experiments with the N domain deletions. I investigated the activity of these deletion 
constructs in the different host strains. Furthermore, I investigated the activity of the 
chimeric protein constructs, FepNFhuβ and FhuNFepΒ. 
Fhuβ is inactive in OKN73, the strain with the complete deletion of 
genomically encoded FepA and FhuA. The construct is inactive in MB97 (fhuA). It is 
however active in KDF541. The fhuA locus of KDF541, the original host of Fhuβ
constructs, has not been sequenced and therefore the exact nature of its fhuA-
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phenotype has not been characterized. I obtained a wild type length PCR product from 
the genome of KDF541 using primers that anneal upstream and downstream of the 
fhuA gene. However, the strain does not express any detectable FhuA protein. This 
implies that the mutation is likely a frameshift mutation rather than a deletion in the 
gene. The exact location of the mutation is unknown. The strain also contains a 
residual 363 amino acid N terminal fragment of FepA (see below). The 
uncharacterized FhuA fragment and/or the FepA fragment may complement the Fhuβ
protein. The fact that Fhuβ is inactive in MB97, which does contains full length active 
FepA, implies that the protein needs the FhuA fragment. It has been reported that a 
352 amino acid FhuA fragment is present in one of the original two strains used for 
studies on Fhuβ and has later been postulated as the complementing factor (Braun 
2003).  
Regarding Fepβ, the proteins are inactive in the strain (OKN73) with complete 
fepA and fhuA deletions. The presence of wild type FhuA (in OKN3) failed to 
complement the construct. In KDF541, the original host for these constructs, they are 
active. The fepA- phenotype of KDF541 was engineered by selecting for spontaneous 
colicin B resistance. The strain however contains a residual 363 amino acid N 
terminal fragment of FepA. This fragment or a similar uncharacterized FhuA 
fragment (see above) is apparently able to complement the activity of Fepβ. The 
coexpression of plasmid encoded FepN also accomplished complementation, although 
not as well as the FepA1-363 fragment. 
The chimeric protein constructs present a more complicated picture. 
FepNFhuβ behaves like Fhuβ in that it is not active in fepA-fhuA- OKN73 or fhuA-
MB97. Like Fhuβ, it is active in KDF541. FhuNFepβ behaves like FepΒ. It is not 
active in fepA-fhuA- OKN73 or fepA- OKN3. However, like Fepβ it is active in 
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KDF541. This implies that the chimeras also undergo complementation by 
genomically encoded fragments. 
The disposition of the attached N domain is relevant to this discussion. The 
domain may be inserted into the barrel or may remain suspended in the periplasm. In 
the latter case, the chimeras will exist as hollow barrels like the deletion constructs. 
While this may explain their functional similarity to the deletions, evidence exists that 
argues against this theory. In strain KDF541, Fhuβ confers increased susceptibility 
and hence, permeability to the antibiotic bacitracin, but FepNFhuβ does not. In the 
same vein, Fepβ and FhuNFepβ confer different antibiotic sensitivities to KDF541. 
When compared to Fepβ, FhuNFepβ shows reduced permeability to bacitracin and 
erythromycin (Scott 2001). In both cases, the antibiotic susceptibility profile of 
chimeric proteins mirrored that of the wild type LGPs but not the deletions. This 
suggests that the chimeric protein does not exist as a hollow barrel. The barrel is filled 
with either the attached N domain or the N domain from the complementing factor. If 
the latter is true, then it suggests that the final configuration of even the chimeras 
resembles wild type LGPs. However, the chimeras function with a reduced capacity 
of binding and the Vmax of transport just like the deletions. Vakharia et al. postulated 
that the lower values detected with the deletions may reflect the lower efficiency of 
the complementation (Vakharia 2002). If that is true, it is imaginable that the 
chimeras are complemented with comparable or even lower efficiencies. This would 
leave most of the chimeric barrels empty. The difference in the antibiotic sensitivities 
between the deletion and the chimera argues against this possibility. It is therefore 
likely that the barrels are filled with their attached N domains. In light of these 
considerations, it is not clear how the genomically encoded fragments displace the 
preexisting N-domains and complement the chimeras. The probable location of the 
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genomically encoded fragments further complicates the picture. Murphy et al. found 
that N terminal segments of FepA (like the genomically encoded FepA1-363) longer 
than 210 amino acids localize to the OM (Murphy 1989). From this tethered location, 
the N domains from the fragments would have to complement the empty barrels. 
Unlike lamB and other specific porins, no reliable evidence exists that LGPs like 
FepA and FhuA form trimers. In the absence of such oligomerization, it is not 
apparent how the fragments attain the proximity needed to complement the deletion or 
chimerical proteins. The said complementation may not happen at the level of the 
mature proteins but at the level of protein expression. The current evidence also does 
not rule out this possibility. 
Disposition of the N domain of FhuA during transport 
The N domain of ligand-gated porins completely seals off the barrel in the 
crystal structure, prompting the denomination ‘plug’ domain (Buchanan 1999). 
However, this description suggests that this domain blocks transport through the 
barrel. The absence of LGP transport in its absence (Vakharia 2002, Braun 2003, this 
study), its independent binding of FeEnt (Usher 2001) and its complementation of the 
empty barrels (Braun 2003, this study) indicates that the N domain plays the role of an 
usher than a bouncer. However, it may be the plug against bacterial toxins including 
antibiotics and bile acids. In light of its specific role, the best description therefore lies 
in the name, N domain. 
The first step in the mapping of the N domain’s disposition is to identify its 
orientation when the transporter is quiescent. Does the N domain reside inside the 
barrel? Or is it suspended in the periplasm? In other words, does the crystal structure 
describe the receptor in vivo? The complementarity between the ion pairs of the two 
domains argues against an artifactual localization of the N domain. Biochemical 
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evidence exists that help to support and interpret the structural data. The disruption of 
the native disulfide by W101C, the absence of similar observations with other 
cysteine mutants which do not have anatomic proximity to the native cystine in the 
mature protein and the difference in the antibiotic permeabilities of the native protein 
and the beta barrel (Scott 2001, Braun 1999) indicates that the N domain does reside 
inside the barrel in vivo. However, it does not indicate whether this arrangement is 
transient or continuous. If the N domain is within the barrel, then transport requires a 
change in its conformation. We attempted to determine such conformational changes 
with the TEV protease experiments. The permeablization of the E. coli cell wall 
delivers the TEV protease into the periplasm. 
Our experiments with the control substrate show that the introduced TEV 
protease is active in the periplasm of E. coli. The techniques employed delivered TEV 
protease activity to the target location. However, I did not observe proteolytic 
cleavage of our FhuA TEV site constructs. This suggests that there is no accessibility 
of the TEV sites in the N domain to TEV protease. However, other technical factors 
may affect this conclusion. 
Even with the soluble target substrate, less than 50% of the target is cleaved in 
our strains. Therefore, the N terminal fragment of the OM protein may not be 
generated in sufficient concentration to be visible on an immunoblot. Most 
experiments in our laboratory are performed using the 125I-Protein A immunoblotting. 
This is a specific technique that also has the added advantage of being precisely 
quantitative. However, in order to detect the proteolytic fragments even at lower 
concentrations, I used the more sensitive but less specific colorimetric western 
blotting. However, these experiments were not successful. I also experimented with 
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several variables to increase the activity of the TEV protease, but did not achieve 
FhuA target proteolysis. 
I was not able to demonstrate a control reaction at the inner surface of the OM. 
In the absence of demonstrated activity at this location, the TEV protease experiments 
do not allow any conclusions about the disposition of the N domain. With limited 
success with protease methodologies, I shifted to other approaches.
Disposition of the N domain of FepA during transport 
The accessibility to fluorophore labeling is an indicator of a residue’s 
disposition in vivo (Henderson 2004). G54C exhibits differential labeling accessibility 
in vivo under different physiological conditions. Glycine 54 exists in a buried location 
in the crystal structure. The mutation G54C does not affect the functionality of FepA. 
Therefore, any change in the disposition of glycine 54 would be expected to indicate 
the spatial orientation of the N domain. The fluorophores labeled FepAG54C in 
OKN3 both in the presence and absence of FeEnt. This happened both at 37°C and 
0°C. In OKN13, it labeled only in the absence of FeEnt. 
AM penetrates the periplasm. Nevertheless, stearic hindrance presumably 
interferes with labeling at I14C and G300C in the absence of FeEnt. When the ferric 
siderophore is added, the change in conformation of the tonB box or the entire N 
domain exposes I14C. This is consistent with the movement in the tonB box described 
in the FhuA and FecA crystal structures (Locher 1998, Ferguson 2002). The 
continued absence of G300C labeling under the latter conditions implies that this 
cysteine is still shielded. 
If a pore develops in the presence of transport or ligand binding, it may allow 
AM to attack the cysteines from either the surface or the periplasm. However, the 
fluorophores do not enter the barrel as evident from the results with G565C. The 
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observed labeling at G54C and the absence of the same at G565C is not consistent 
with the formation of a pore. 
A pore is not inconsistent with, albeit not essential to, the increase in I14C 
labeling by AM in the presence of FeEnt. However, it raises the question why the 
pore does not support labeling by AM at G300C. Alternatively, the N domain may 
traverse superiorly and expose I14C to AM upon ligand binding. However, such a 
movement will expose G300C to AM labeling from the periplasm, which is not 
observed. .  
Another alternative will be the creation of a crescent shaped pore in the barrel 
which will allow both the ferric siderophore and the fluorophore to enter the protein 
simultaneously. Since I14C and G54C are located on different faces of the N domain, 
this may explain the absence of labeling at G54C and the opposite at I14C in tonB-
strains. FeEnt may block the fluorophore from reaching G54C but not I14C. The 
depth of penetration may not give the fluorophore access to G300C. On the contrary, 
in OKN3, transport may unblock the fluorophore from G54C. However, this scenario 
will not account for lack of G565C labeling. This leaves us only the solitary 
conclusion that the labeling of G54C takes place in the periplasm. 
The model (Figure 52) that develops out of these experiments involves the 
movement of the N domain in and out of the barrel. In the absence of tonB and/or 
ligand, the N domain either stays inside the barrel or cycles between inserted and 
periplasmically suspended states. In the suspended state, the surface loops may slope 
towards each other and guard the channel. This is consistent with the absence of Fepβ
cross-linking to OmpA (Scott 2003). Upon ligand binding, the loops close over FeEnt 
and make it solvent inaccessible from the exterior of the cell. Further movement 
ceases until the transport signals are transmitted by the loops. The N domain leaves 
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the barrel alone or with attached ligand. In the former case, the ligand diffuses out of 
the barrel as its local concentration in the confines of the barrel will be of the order of 
50 M. In the latter case the release of the ligand may happen by transient denaturation 
of the N domain. After the ligand is transported into the periplasm, presumably into 
the reaches of FepB, the reassembly of the protein occurs and the surface loops attain 
the open, ligand binding conformation. 
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Figure 52. Model of FeEnt transport through FepA. (Top) Formal representation of the FepA 
transport process. Constants k1 to k4 are experimentally defined (Cao 2003, Annamalai and Jin 2004). 
(Bottom) FepA’s transport cycle is depicted as a series of conformational stages that result in binding 
and internalization of FeEnt. The representations of FepA are based on the crystal structure, but the 
stages are postulated models not crystallographically demonstrated. FeEnt binding causes the surface 
loops to close over the ligand. Subsequently, the N domain exits the barrel. The ligand passes through 
the C-domain channel (Transport). TonB and/or energy may function during this phase of the transport 
reaction. After transport the receptor reassembles by reinsertion of the N domain into the β-barrel, 
another potential phase for the input of energy and/or TonB. Lastly, the loops reopen to achieve a 
binding competent conformation (Figure by Klebba in Annamalai and Jin 2004). 
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